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THE EFFECT OF GLOBAL CONTROL ELEMENTS ON THE 
EXPRESSION OF ywfH GENE IN B. subtilis  
SUMMARY 
In Bacillus subtilis species, sporulation, genetic competence, and antibiotic 
production are controlled by quorum-sensing global regulatory mechanism. Bacilysin 
is a simple and small sized (125kDa) dipeptide antibiotic which is produced 
extracellularly by certain species of Bacillus subtilis that consists of L-alanine 
residue at N-terminus and non proteinogenic L-anticapsin residue at C terminus 
which is produced extracellularly by certain species of Bacillus subtilis. In previous 
studies, we showed that the biosynthesis of bacilysin is under the control of quorum 
sensing global regulatory pathway through the action of ComQ/ComX, PhrC (CSF), 
ComP/ComA in a Spo0K (Opp)-dependent manner. Recently, It was found that a 
polycistronic operon (ywfBCDEFG) and a monocistronic gene (ywfH) are required 
for the biosynthesis of bacilysin in Bacillus subtilis. The main purpose of the present 
study is to monitor the effects of previously-identified genes srfA, oppA, comA, 
phrC, phrF, phrK, comQ (comX), comP, spo0H, spo0A, abrB, codY, degU and sigB 
on the expression of ywfH gene. Firstly, to analyze ywfH expression, a B. subtilis 
strain, NAO1, containing ywfH-lacZ fusion at the ywfH gene region was constructed. 
Then, each of the above-mentioned genes of cell density signaling was insertionally 
inactivated or deleted in NAO1. The resulting mutant strains and NAO1 as control 
were cultured in PA medium at 37
o
C and ywfH- directed β-galactosidase activities 
were monitored.  
Mutations in codY,  comP, comA, comQ(comX), phrC, phrK ,phrF, srfA, spo0H, and 
spo0A genes completely abolished ywfH-lacZ expression. Moreover, abrB null 
mutation gradually relieved the repression of ywfH during exponential phase. 
Complete inhibition of ywfH expression in Δspo0A strain was not restored by abrB 
mutation. On the other hand, ywfH expression severely decreased but did not become 
completely eliminated during the stationary phase in codY mutant strain. However, 
abrB-codY double mutations resulted in an increase in  ywfH expression in 
exponential phase. In this study, we also found that ywfH expression is subject to 
nutritional repression mediated by Casamino acids. The effect of a transition 
regulator gene degU and general stress control element sigB gene on the expression 
of ywfH gene were also investigated and we found that  ywfH expression is positively 
regulated by DegU. On the other hand, sigB deletion mutation didn’t cause a 
considerable difference in ywfH expression.  
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GLOBAL KONTROL ELEMANLARININ B. subtilis’TE YER ALAN ywfH  
GENİNİN İFADESİ ÜZERİNDEKİ  ETKİLERİ 
ÖZET 
Bacillus subtilis türlerinde, sporulasyon, genetik kompetans ve antibiyotik üretimi, 
hücre yoğunluğu sinyal mekanizması ile kontrol edilmektedir. Basit ve küçük 
boyutlu bir dipeptit antibiyotik olan bacilisin, L-alanin ve L-antikapsinden ibaret 
olup, belli başlı bazı Bacillus subtilis türleri tarafından ekstrasellüler olarak 
üretilmektedir. Basilisin biyosentezinin, ComQ/ComX, PhrC (CSF), 
ComP/ComA’nın etkisinde hücre yogunluğu sinyali mekanizmasının kontrolü altında 
olduğunu ve bunun Spo0K (Opp)’ye bağlı bir biçimde gerçekleştiğini daha önceki 
çalışmalarımızda göstermiştik. Yakın zamanda, basilisin biyosentezi için bacABCDE 
olarak yeniden  isimlendirilen ywfBCDEFG operonuna ve ywfH genine ihtiyaç 
duyulduğu belirtilmiştir.  
Şu an yapılmış olan çalışmamızın ana amacı, daha önceden tanımlanmış olan srfA, 
oppA, comA, phrC, phrF, phrK, comQ (comX), comP, spo0H, spo0A, abrB, codY, 
degU and sigB  genlerinin,  ywfH geninin ifadesi üzerindeki etkisini göstermektir. Bu 
amaçla, ywfH gen bölgesinde ywfH-lacZ füzyonu  içeren  bir Bacillus subtilis türüne 
ait NAO1 suşu oluşturulmuştur. Yukarıda belirtilmiş olan hücre yoğunluğu sinyal 
mekanizması genleri,  NAO1suşu içerisinde inaktif edilmiştir. Oluşan mutant suşlar 
ve kontrol olarak NAO1 suşu, 37oC’de PA ortamında kültür edilmiş ve ywfH’a bağlı 
β-galaktosidaz aktiviteleri gösterilmiştir.  
codY,  comP, comA, comQ(comX), phrC, phrK ,phrF, srfA, spo0H, and spo0A 
genlerinde meydana gelen mutasyonlar ywfH-lacZ ifadesini tamamen ortadan 
kaldırmıştır. abrB mutasyonu, ywfH geninin büyüme fazındaki baskılanmasını 
kademeli olarak azaltmıştır. Durağan faz boyunca, Δspo0A mutant suşunda tamamen 
engellenen ywfH gen ifadesi abrB mutasyonuna rağmen eski haline getirilememiştir.  
Bunun yanında, codY mutant suşunda, ywfH gen ifadesi durağan faz sırasında fazla 
miktarda azalmış fakat tamamen ortadan kalkmamıştır. Ayrıca, abrB-codY çift 
mutasyonunda, exponansiyel büyüme fazında ywfH gen ifadesinde artış olduğu 
görülmüştür. Bu çalışmada,  ywfH gen ifadesinin kazamino asit varlığında besinsel 
baskılamaya da maruz kaldığı bulunmuştur. Geçiş evresi düzenleyici gen olan degU  
ve  genel stres kontrol elemanı olan sigB geninin ywfH geni üzerindeki etkisi 
araştırılmış ve  DegU ürününün ywfH geninin ekpresyonunun düzenlenmesinde 
pozitif rol oynadığı bulunmuştur. Öte yandan  sigB geninde meydana gelen 
mutasyonun, ywfH geninin ekpresyonu üzerinde kayda değer bir etkisinin olmadığı 
görülmüştür. 
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INTRODUCTION 
1.1.  Bacillus subtilis 
B. subtilis is an aerobic, endospore-forming, rod-shaped Gram positive bacterium 
which has ability to secrete many secondary metabolites, as well as over two dozen 
of ribosomal and non-ribosomal antibiotics that have antibacterial, antifungal and 
antimetabolic features.  B. subtilis are obtained especially in terrestrial and aquatic 
environments such as soils, plant roots, gastrointestinal system of animals and water 
sources.  
In a situation of nutritional limitation or other environmental stresses, Bacillus 
subtilis cells create many adaptative responses in order to survive. Their highly 
resistant dormant endospores are also a response to these situations. Additionally, B. 
subtilis can grow under anaerobic conditions if nitrate is added as the terminal 
electron acceptor to the environment (Earl et al. , 2008, Harwood et al., 1996, Glaser 
et al., 1995, Ramos et al., 1995, Stein et al., 2005). 
B. subtilis became a very studied model organism owing to its metabolic diversity, 
non-pathogenicity, ability to produce hydrolytic enzymes (e.g. alkaline proteases, 
amylases), polypeptide antibiotics (e.g. bacitracin), biochemicals (e.g. nucleosides 
for conversion to flavour enhancers) and insecticides (e.g. 8-endotoxins) especially 
after the sequencing of its genome (Kunst et al., 1997, Harwood et al., 1996). 
On the other hand, B. subtilis shows health-beneficial properties. Especially, its 
probiotic property, which is primarily found in spore form, helps to prevent 
gastrointestinal disorders. Also, it is clearly confirmed that B. subtilis can alternate 
many antibiotics by being a novel prophylactic, therapeutic and growth promoting 
agent (Hong et al., 2004, Williams, 2007, Fujiya et al., 2007).  
Bacillus subtilis is a chemoorganotroph that has the ability to survive when exposed 
to very simple growth conditions such as simple salt medium containing glucose or 
other sugars as carbon and energy source, inorganic nitrogen and adequate supply of 
oxygen (Nicholson and Setlow, 1990). 
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As similar to many other members of Bacillus genus, B. subtilis, is mesophilic and 
can grow as normal-sized colonies within a day at 37
o
C (Harwood et al., 1990). If 
nutrients become limiting for optimal growth at the end of the exponential phase, B. 
subtilis develops a motility and chemotaxis system to be able to search for nutrients 
in order to prevent this limitation for the ultimate purpose of surviving. If there is 
still a limitation at the stationary phase, these cells start to secrete antibiotics and 
enzymes such as proteases to reach nutrients from alternative resources which are 
normally hard to reach. Furthermore, B. subtilis exhibits genetic competence 
development by uptaking exogenious DNA and sporulation when nutritional 
limitation continues. All of these properties cause B. subtilis to earn advantage of 
surviving and eliminate other bacteria for nutrient competition (Hamoen et al., 
2003). 
Genome of Bacillus subtilis is 4.214.810 base pair long including 4106 protein-
coding genes (Kunst et al., 1997, Kobayashi and Ogasawara, 2002). Also 86 tRNA 
genes, 30 rRNA genes and three small stable RNA genes are annotated on 4215 kb 
genome beside these 4106 protein-coding genes. When the sequence was published, 
possible function was assigned to about 58% of all genes (2379 genes) but the 
number of the genes with assigned function has increased to 63% (2562 genes) in the 
current database. (Kobayashi and Ogasawara, 2002). On the other hand, 4% of 
essential genes display unknown functions (Kobayashi et. al., 2003). 
1.2. Quorum Sensing Mechanism As A Regulatory System of Gene Expression 
Bacteria are found in nature as microbial communities more than as individuals and 
this situation gives them the advantage of having interactions among them and 
surviving in different ecological habitats (Lazdunski et al, 2004). Therefore, 
generally, species of bacteria are social organisms with intercellular communication 
(Ruzheinikov et al., 2001). This communication consists of chemical signal 
molecules that gives them ability of sensing the presence of other bacteria and 
generally cause cooperative production for the benefit of population which is not 
efficient for an individual to perform by itself (von Bodman et al., 2008).  
When these signal molecules accumulate and a quorum (e.g. certain threshold 
concentration) is reached, bacteria cooperationally behave in order to survive by 
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using chemical signal molecules in response to environmental alterations and this 
process is called ‘’Quorum Sensing(QS)’’(Miller et al., 2001, Gobbetti et al. 2007). 
In QS mechanism, different signalling molecules, signal detection systems and signal 
transduction mechanisms are used by both Gram negative and Gram positive bacteria 
(Lazdunski et al, 2004).  
Gram-negative LuxIR circuits and Gram-positive oligopeptide two-component 
circuits are two general types of bacterial quorum sensing mechanisms. (Taga et al., 
2003). In Gram-negative bacteria, signalling molecules are typically acylated 
homoserine lactones (AHLs) and in Gram-positive bacteria, peptides are generally 
the signalling molecules (Lazdunski et al., 2004; Fuqua and Greenberg, 1998). There 
are known cases of bacterial regulation of gene expression in response to cell-cell 
signaling. For example, bioluminescence in Vibrio fischeri , plasmid conjugation in 
Agrobacterium tumefaciens, biofilm production and virulence gene expression in 
Pseudomonas aeruginosa, expression of factors necessary for symbiosis in 
Sinorhizobium meliloti, antibiotic production in Erwinia carotovora and 
Streptomyces spp., conjugation in Enterococcus faecalis, genetic competence in 
Bacillus subtilis and Streptococcus pneumonia (Miller et al., 2001; Taga et al., 2003; 
Sturme et al., 2002; von Bodman et al., 2008).  
In B. subtilis, QS contributes different processes such as genetic competence 
development, sporulation, production of antibiotics and degradative enzymes 
(Griffith and Grossman, 2008). Also, sporulation and the development of genetic 
competence are stimulated as cells grow to high density. Sporulation regulation at 
high cell density needs several extracellular/environmental signals and this regulation 
is controlled certainly via a quorum sensing mechanism (Lazazzera et al., 1997; 
Miller et al., 2001).  
The dependence of sporulation and competence on both an extracellular signal and 
an oligopeptide permease operon model suggests that after accumulation of signal 
peptide, this signal can move through the oligopeptide permease and function 
intracellularly in the target cell. In a Bacillus population, this signal acts as a quorum 
sensor and helps individuals of population to sense other cells under limited 
nutritional conditions or to get prepared for DNA-uptake  (Solomon et al., 1996; 
Magnuson et al., 1994). 
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In Bacillu subtilis QS system, there are two peptides called ComX and CSF 
(competence and sporulation factor) which mediate QS control of competence and 
regulate the activity of the transcription factor ComA (Figure1.1) (Solomon et al., 
1995 and 1996; Lazazzera et al., 1997). ComX and CSF are both secreted and 
accumulated as cell density increases (Miller et al., 2001). ComX peptide, a 10 
amino acids (ADIPITRQWGD) long peptide which has a hydrophobic modification 
on tryptophan residue that is required for signaling activity, is the major extracellular 
signaling peptide. ComX interacts with unmodified pentapeptides, known as Phr 
peptides, that are internalized to inhibit the activity of their target proteins, known as 
Rap proteins (Lazazzera, 2001; Perego and Brannigan, 2001; Stein, 2005). 
B. subtilis encodes a family of 8 Phr peptides (PhrA, PhrC, PhrE, PhrF, PhrG, PhrH, 
PhrI, and PhrK) and a family of 11 Rap proteins (RapA to RapK) (Table 1.1) Each 
Phr peptide is encoded in an operon with a Rap protein, and each characterized Phr 
inhibits the activity of its Rap protein (Auchtung et al., 2006). 
 
 
 
 
 
 
 
 
 
 
Figure  1.1:  Regulation mechanism of quorum responses triggered by   
environmental signals and initiation of signal transduction cascade through  ComX 
and CSF diffusible peptides (Lazzazera, 2000). 
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Table 1.1:  Processes regulated by rap proteins and phr peptides in B. subtilis 
(Auchtung et al., 2006). 
Rap 
Protein 
Phr 
peptide 
Target(s) 
of Rap 
Mechanism 
of Rap 
Responses regulated by 
target protein(s) 
RapA PhrA Spo0F~P Stimulates 
Autodephos 
phorylation 
Activates post exponential-
phase gene exp. and 
sporulation indirectly 
through Spo0A 
RapB PhrB Spo0F~P Stimulates 
autodephos 
phorylation 
Activates post exponential-
phase gene exp. and 
sporulation indirectly 
through Spo0A 
RapC PhrC ComA Inhibits binding 
Of ComA to 
DNA 
Activates expression of genes 
involved in production of 
degradative enzymes, 
antibiotics and competence, 
RapD  Unknown Unknown  
RapE PhrE Spo0F~P Stimulates 
autodephos 
phorylation 
Activates post exponential-
phase gene exp. and 
sporulation indirectly 
through Spo0A 
RapF PhrF ComA Inhibits binding 
Of ComA to 
DNA 
Activates expression of genes 
involved in production of 
degradative enzymes, 
antibiotics and competence, 
RapG PhrG DegU, 
ComA 
Inhibits binding 
of DegU to DNA, 
Unknown 
Activates expression of genes 
involved in production of 
degradative enzymes, 
antibiotics and competence, 
RapH PhrH DegU, 
ComA 
Unknown Activates expression of genes 
involved in production of 
degradative enzymes, 
antibiotics and competence, 
RapI PhrI Unknown Unknown RapI stimulates gene 
expression, excision, and 
transfer of  ICEBs1 
RapJ  Unknown Unknown  
RapK PhrK ComA Unknown Activates expression of genes 
involved in production of 
degradative enzymes, 
antibiotics and competence, 
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Additionally a protein called ComQ is required for production of ComX peptide but 
the specific role of this protein is unknown. The accumulation of ComX signal is 
detected by two regulators called ComP and ComA (Magnuson et al., 1994; Solomon 
et al., 1995). In this system, firstly ComX binds to and activate a protein kinase,  
ComP . Then ComP donates phosphate its phosphate group to ComA, a 
phosphorylation-dependent response regulator transcription factor.  After that, by the 
generation of ComA~P, the quorum response genes, degQ, rapC, rapA and srfA are 
activated (Figure 1.1). Nonetheless, ComA is inactive when the ComX signal peptide 
concentration is low and if only the signal peptide concentration increases, ComA 
gets activated (Magnuson et al., 1994; Solomon et al., 1995 and 1996; Weinrauch et 
al., 1990; Griffith and Grossman, 2008). 
The expression of degQ is involved in the regulation of degradative enzyme 
synthesis. Other quorum sensing response genes rapA and rapC encode phosphatases 
involved in the control of competence development and sporulation. The srfA operon 
encodes a small protein ComS and the surfactin biosynthetic enzymes (Nakano et al., 
1991).  
ComA~P activates the production of ComS protein. ComS inhibits the proteolytic 
degradation of a transcriptional activator, ComK protein, which drives its own 
transcription. After ComS transcription, ComK concentration increases in the cell 
quickly and structural genes of competence are expressed resulting DNA-uptake into 
the cell (van Sinderen et al. 1995;  Turgay et al., 1997 and 1998). 
There are also other peptides that stimulate ComA activity such as ComX, the CSF, 
PhrF, PhrK, PhrH. In addition to master extracellular signaling peptide ComX, the 
second key quorum sensing peptide in Bacillus subtilis is a competence and 
sporulation factor, CSF peptide, which is a diffusible pentapeptide. CSF (ERGMT) is 
encoded from rapC-phrC operon which encodes both CSF and its cytoplasmic 
receptor RapC. The CSF signal molecule is formed by cleavage of five amino acids 
at the C-terminus of the precursor peptide, PhrC. The mechanism of the CSF peptide 
on ComA regulation is more complex than ComX peptide. The increase of cell 
density stimulates the accumulation of CSF peptide  extracellularly. CSF peptide is 
transported back into the cell after it reaches its critical concentration by oligopeptide 
permease Opp, which is an ATP-binding casette transporter belonging ABC-type 
oligopeptide transporter family. Following the intake of this peptide, there are two 
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different intracellular receptors to which CSF peptide binds to regulate the activity of 
the ComA transcription factor. (Pottahil et al., 2008; Solomon et al., 1995 and 1996; 
Lazazzera and Grossman, 1998; Lazazzera 1997; Perego, 1997).When the 
intracellular concentration of CSF is low (1-5 nM), CSF binds to and inhibits RapC 
which is ComA-specific aspartylphosphate phosphatase. Low levels of intaken CSF 
promote competence development because of the inhibition of RapC helps the 
increase of phospho-ComA which is a regulator controlling the expression of 
competence genes (Solomon et al., 1996). At higher concentrations (>20 nM), CSF 
inhibits the expression of comS that cause ComK proteolysis which is necessary in 
the decision of competence development. Also, at high concentration condition, CSF 
inhibits an aspartyl-phosphate phosphatase, RapB that dephosphorylates a response 
regulator (Spo0A) which is important at the initiation of sporulation (Figure 1.2). 
Inhibition of the RapB phosphatase activity increases the levels of phospho-Spo0A. 
Therefore, on both case, it is obvious that CSF stimulates sporulation at high internal 
concentration (Miller et al., 2001). 
The initiation of sporulation in Bacillus subtilis is regulated by a phosphorylation-
mediated signal transduction pathway, known as phosphorelay (Stephens, 1998). 
 
Figure 1.2: Sporulation initiation in B.subtilis (von Bodman et al., 2008). 
In the quorum sensing mediated sporulation mechanism of Bacillus subtilis, not only 
CSF (PhrC), but also a peptide, ARNQT (PhrA) which is encoded by phrA gene 
takes part and transported into the cell by Opp. These peptides are responsible for 
inhibition of phosphotases RapB and RapA respectively, which dephosphorylate 
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Spo0F~P. Additionally, KinA, KinB and KinC also has specific roles in the 
production of Spo0A. Beside other response regulators, phosphate transfer to Spo0A 
is not direct from kinases. In Spo0A phosphorylation, firstly, phosphate is transferred 
from kinases to Spo0F protein and Spo0F~P is formed. Then phosphate is transferred 
to Spo0B and Spo0B~P is formed. After that phosphate transferred to Spo0A and 
Spo0A~P protein is formed finally (Figure 1.3) (Stephens, 1998; Perego et al., 1994). 
 
Figure 1.3: Phosphorelay signal transduction system 
1.3. Bacilysin : A Dipeptide Antibiotic  
The potential of B. Subtilis to produce antibiotics has been recognized for 50 years. 
Peptide antibiotics represent the predominant class. They exhibit highly rigid, 
hydrophobic and/or cyclic structures with unusual constituents like D -amino acids 
and are generally resistant to hydrolysis by peptidases and proteases (Stein, 2005). 
Bacilysin [L-alanine-(2.3-epoxycyclohexanone-4)-L-alanine] is a simple and small 
sized(125kDa) nonribosomally synthesized dipeptide antibiotic that consists of L-
alanine residue at N-terminus and non proteinogenic L-anticapsin residue at C 
terminus (Figure 1.4) (Walker and Abraham, 1970). This antibiotic is active against a 
wide range of bacteria and fungi  especially Candida albicans (Steinborn et al., 
2005). 
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Figure 1.4 : The structure of bacilysin (Walker and Abraham, 1970). 
The anticapsin moiety of bacilysin is important at the antibiotic activity which is 
released by peptidases after bacilysin uptake into susceptible cells by a distinct 
peptide permease system. After its uptake, the intracellular anticapsin blocks 
glucosamine synthetase that is responsible for bacterial peptidoglycan or fungal 
mannoprotein biosynthesis (Kenig et al., 1976; Perry and Abraham 1979, Chmara et 
al., 1981). This situation leads to cell protoplasting and lysis. The antibiotic activity 
of anticapsin becomes specifically antagonized by glucosamine or N-
acetylglucosamine depending on its metabolic target (Walton and Rickes 1962; 
Kenig and Abraham, 1976). 
The synthesis of anticapsin branches from prephenate of the aromatic acid pathway 
which is the primary precursor of bacilysin (Hilton et al., 1988). The peptide bound 
with L-alanine proceeds in a non-ribosomal mode, catalysed by bacilysin synthetase 
which is an amino acid ligase (Sakajoh et al., 1987). 
Bacilysin production of B. subtilis is connected with the active growth in a synthetic 
medium and is inhibited by certain growth conditions, especially in the presence of 
certain nutrients, such as glucose or casaminoacids, and/or physiological factors, like 
pH, temperature (Özcengiz et al. 1990; Özcengiz and Alaeddinoglu 1991; Basalp et 
al. 1992). 
Bacilysin biosynthesis is under or a component of the quorum sensing pathway 
which is responsible for the establishment of sporulation, competence development 
and onset of surfactin biosynthesis. In this pathway, besides ComQ/ComX, PhrC 
(CSF), ComP/ComA, also  their  unique transporter Spo0K (Opp) and products of 
srfA, spo0A, spo0H and abrB genes are defined as parts of quorum sensing 
mechanism and have key roles on regulatory circuit of  bacilysin biosynthesis 
(Karataş et al., 2003). 
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Figure 1.5: Biosynthesis pathways of subtilin, subtilosin, bacilysin, surfactin 
antibiotics, the killing factor Skf and the spore-associated anti-microbial polypeptide 
TasA in B. subtilis (Stein, 2005). 
Bacilysin production is regulated on different levels negatively by GTP via the 
transcriptional regulator CodY and AbrB (Inaoka et al., 2003; Yazgan et al., 2003). 
In B. subtilis, the production of antibiotics and resistance to them are under the 
control of the transition state regulator AbrB. As a typical example, tycA operon 
which encodes the enzyme tyrocidine synthetase catalyzing the synthesis of a cyclic 
decapeptide is directly repressed by AbrB which interacts with sequences upstream 
and downstream of the promoter and controls stationary-phase expression of tycA 
(Guespin-Michel, 1971; Furbah et al., 1991). 
A polycistronic operon (ywfBCDEFG) renamed as bacABCDE,  and a monocistronic 
gene (ywfH) are required for the bacilysin biosynthesis (Figure 1.6) (Steinborn and 
Hofemeister 1998/2000; Inaoka et al., 2003).  Each gene of the operon has specific 
functions; bacABC (ywfBCD) encode proteins functioning in the biosynthesis of 
anticapsin, bacD (ywfE) in the (amino acid) ligation of anticapsin to alanine and 
bacE (ywfF), in self-protection from bacilysin. ywfB and ywfG encode  prephenate 
dehydratase and an aminotransferase, respectively, which are responsible for  
anticapsin production from prephenate of the aromatic amino acid pathway. The 
function of ywfH gene is still unkown but YwfH can be assigned to be involved in 
the alanine-anticapsin ligation. On the other hand,  the direct evidence to 
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involvement in bacilysin synthesis was displayed for ywfH by gene disruption 
experiments or by missense allele analysis (Inaoka et al., 2003).  
Figure 1.6:   Organization of the bacilysin gene cluster ywfABCDEFG and ywfH 
gene of Bacillus subtilis 168 (Inoaka et al., 2003). 
While the ribosome system is universal, other machineries specific for certain 
peptides are also known, including nonribosomal peptide synthetase (NRPS). NRPSs 
are composed of repetitive units called as modules, each about 1.000 – 1.500 amino 
acids in length, which are capable of incorporating one amino acid constituent at a 
time into peptide chain. The modules can be subdivided into domains, each 
responsible for catalyzing the three basic reactions: substrate recognition, activation 
as acyl adenylate, and covalent binding as thioester. (Mootz and Marahiel, 1997; 
Schwarzer and Marahiel, 2002; Tabata et al., 2005).  
It was thought that formation of bacilysin was carried out by multiple-carrier 
thiotemplate mechanism until recently. But its biosynthesis mechanism was not fully 
coupled to non-ribosomal peptide synthetase (NRPS) mechanism because of the fact 
that adenylation and thiolation were obvious only for L-alanine, but not for L-
anticapsin (Yazgan et al., 2001).  
Bacilysin production is regulated on different levels of positive and negative 
regulations. Positive regulation is conducted by guanonsine 5’-diphosphate 3’-
diphosphate (ppGpp) (Inaoka et al., 2003) and by a quorum-sensing mechanism 
through the peptide pheromone PhrC (Yazgan et al., 2003). Guanosine 5’-
diphosphate 3’-diphosphate (ppGpp) plays a crucial role in transcription of the 
ywfBCDEFG operon and that the transcription of these genes is dependent upon the 
level of intracellular GTP which is transmitted as a signal via the CodY-mediated 
repression system. The CodY regulon encodes extracellular degradative enzymes, 
catabolic enzymes, transporter proteins, genetic competence factors, chemotaxis 
proteins antibiotic synthesis pathways, sporulation proteins. Genes and/or operons in 
this regulon are under negative regulation of CodY in the presence of excessive 
glucose or casamioacids (Ratnayake-Lecamwasam et al.,2001; Shivers and 
Sonenshein 2004).Otherwise, the expression of ywfH gene is dependent upon the 
level of intracellular GTP rather than ppGpp (Inaoka et al., 2003).  
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Bacilysin production is negatively regulated by GTP via the transcriptional regulator 
CodY (Inaoka et al., 2003) and AbrB (Yazgan et al., 2003). In wild-type B. subtilis 
cells, a forced decrease of intracellular GTP increases the expression of these genes. 
By the disruption of codY which regulates stationary phase genes by detecting 
intracellular level of GTP results in an enhancement in their transcription and 
increase of bacilysin production only in wild-type cells. On the other hand, CodY is 
important for the regulation of spo0A and it also represses srfA operon. Therefore, 
when codY gene is deleted, there is an increase in bacilysin production in wild-type 
cells and the repression of oppA, srfA and spo0A disappears. In addition if 
intracellular level of AbrB is under critical threshold rate,  AbrB-dependent 
repression on the production of the various antimicrobials,  antibiotic and the other 
stationary phase-associated products decreases  (Strauch 1993; Strauch an Hoch, 
1993; Inaoka et al., 2003). 
srfA operon encodes the enzyme complex which catalyses the nonribosomal sythesis 
of the lipopeptide antibiotic, surfactin. Expression of srfA operon is induced 
following the onset of stationary phase and regulated by specific regulatory genes 
comP, comA, and spo0K. Transcription of srfA is directly activated by 
phosphorylated form of response regulator ComA and activity of ComA is controlled 
by a membrane-bound histidine protein kinase, ComP and an aspartyl-phosphate 
phosphatase, RapC. RapC is a negative regulator to remove phosphate from ComA 
for inactivation of ComA. ComA~P is produced in response to the accumulation of 
cell-derived two extracellular peptide pheromones ComX(ComQ) and CSF(PhrC). 
ComQ is proposed to activate ComP while CSF is transported back into the cell by 
the oligopeptide permease Opp (Spo0K) where it is proposed to interact with and 
inhibit the activity of RapC srfA also contains the competence regulatory gene comS 
and its product, ComS causes the release of a competence-specific transcription 
factor, ComK which is responsible for transcription of the late competence genes 
(Karataş et al., 2003; Nakano et al., 1991; van Sinderen et al., 1995; Weinrauch et 
al., 1990). 
phrC is partly controlled by sigma factor σH (spo0H gene product)-dependent 
promoter (P2) located at upstream of phrC and internal to rapC. The expression of 
spo0H is repressed by AbrB, the transition state regulator of late-growth gene 
transcription which in turn is repressed by the phosphorylated active form of Spo0A. 
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Phosphorylation of Spo0A results from a series of reactions which are catalysed by 
spo0F response regulator and spo0B phosphoprotein phosphotransferase. spo0H gene 
not only has a role in transcription of phrC, but also it controls the additional gene(s) 
involved in the production of mature CSF with Spo0A and AbrB proteins (Karataş et 
al., 2003).  
DegS and DegU are also sensor and effector proteins that form a two-component 
signal transduction regulatory system, transcribed from sacU locus (Stock et al., 
1989) and they are involved in the production of many types of commercially 
valuable degradative enzymes such as extracellular proteases, α-amylase, proteases 
(Tanaka et al., 1991). 
DegS protein kinase also acts as a DegU phosphatase. The genes coding for the DNA 
uptake and integration machinery are activated by a single transcription factor, the 
competence transcription factor ComK. ComK stimulates its own expression with 
response regulator DegU. Phosphorylated form of DegU is necessary for degradative 
enzyme synthesis and nonphoshorylated form of it required for expression of genetic 
competence (Dahl et al., 1992; Duitman et al., 2007). 
Sigma-B (σB) responds through a complex, multibranched signal transduction 
pathway. Sigma-B control the transcription of operons which are responsible for 
diverse functions and a particular set of environmental conditions are required for its 
exppression such as, excessive heat, ethanol, salt, or acid (Price et al., 2002). 
1.4. The Aim of the Present Study 
Former researches pointed that bacilysin biosynthetic operon bacABCDE (former 
ywfBCDEFG) and a monocistronic gene, ywfH are required for the biosynthesis of 
bacilysin. The aim of the present study was focused on the identification of the 
effects of previously identified global regulatory genes srfA, oppA, comA, phrC, 
phrF, phrK, comQ (comX), comP, spo0H, spo0A, abrB, codY, degU and sigB on the 
expression of ywfH gene. 
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2. MATERIALS AND METHODS  
2.1. Materials 
2.1.1 Bacterial Strains and Plasmids 
B. subtilis PY79, a prototrophic derivative of standart strain B. subtilis 168, was used 
as wild type during this study. The strains and their genotypes that were used in the 
study are listed in Table 2.1.  E. coli Top10F’ [lacIq TN10 (Tetr)}, mcrA ∆ (mrr 
hsdRMS-mrcBC), f80lacZ∆M15 ∆lacX74, deoR, recA1, araD139 ∆(ara-leu)7697, 
galU, galK, rsL,(strr), endA1, nupG) was used as first step as a host strain for further 
B. subtilis chromosomal DNA cloning. As plasmids, pGEM-T Easy Vector (Figure 
2.1) for cloning of PCR products amplified. pMutinT3 (Figure 2.2) was used for the 
construction of ywfH-lacZ transcriptional vector. pDR66 (Figure 2.3) was used for 
co-transformation of B. subtilis cell during transformation period to make easy 
selection of  transformants.  
2.1.2. Culture Media 
Culture media composition and preparation are given in the Appendix A. 
2.1.3. Buffers and Solutions 
Composition and preparation of buffers ans solutions are given in the Appendix B. 
2.1.4. Chemicals and Enzymes 
The chemicals and enzymes, which were used, are given in the Appendix C. 
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Table 2.1:  Bacterial strains and their genotypes used in this study. 
      Strain                Geno Genotype Source 
Bacillus subtilis 
PY79 
Wild type BPS cured protothropic 
derivative of Bacillus subtilis 168 
P.Youngman 
KE10 ∆srfA::erm  K. Appelman 
JMS315  trpC2 pheA1 ∆comQ::spc A. D. Grossman 
BD1658 ∆comP::spc D. Dubnau 
JRL192 ∆comA::cat  A. D. Grossman 
AK3  oppA::Tn10::spc A. Y. Karataş 
BAL373 trpC2 pheA1 ∆abrB::cat  A. D. Grossman 
TMH307 trpC2 unkU::spc ∆codY  A. D. Grossman 
CAL7 ∆phrK7::spc  A. D. Grossman 
JMA163 ∆phrF163::cat  A. D. Grossman 
JMS751 ∆phrC::erm  A. D. Grossman 
CU741 ∆degu::kan A. D. Grossman 
ML6  ∆ML6::cat (sigma B) A. D. Grossman 
NAO1 ywfH::lacZ::erm This study 
NAO3 ∆spo0A::spc  ywfH::lacZ::erm This study 
NAO4 ∆spo0H::spc  ywfH::lacZ::erm This study 
NAO5 ∆abrB::cat  ywfH::lacZ::erm This study 
NAO6 ywfH::lacZ::erm ∆codY::spc This study 
NAO7 ∆spo0A::spc ∆abrB::cat ywfH::lacZ::erm This study 
NAO8 ∆abrB::cat   ywfH::lacZ::erm ∆codY::spc This study 
NAO9 ∆comA::cat  ywfH::lacZ::erm  This study 
NAO10 ∆comP::spc  ywfH::lacZ::erm  This study 
NAO11 ∆comQ::cat  ywfH::lacZ::erm  This study 
NAO12 ∆phrC::erm ywfH::lacZ::erm  This study 
NAO13 ∆phrF163::cat ywfH::lacZ::erm  This study 
NAO14 ∆phrK::spc ywfH::lacZ::erm  This study 
NAO15 oppA::Tn10::spc  ywfH::lacZ::erm This study 
NAO16 ∆deg U::kan  ywfH::lacZ::erm This study 
NAO17 ∆ML6::cat (sigmaB) ywfH::lacZ::erm This study 
NAO18 ∆srfA::erm  ywfH::lacZ::erm This study 
E. coli Top10F’ lacIq TN10 (Tetr)}, mcrA ∆ (mrr-hsdRMS-
mrcBC), f80lacZ∆M15 ∆lacX74, deoR, 
recA1, araD139 ∆(ara-leu)7697, galU, 
galK, rsL,(strr), endA1, nupG 
M.A. Marahiel 
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2.1.5. Maintenance of Bacterial Strains 
B. subtilis strains were grown in Luria-Bertani (LB) liquid medium and kept on 
Luria-Bertani (LB) agar plates at cool (+4 
○
C). E. coli strains were kept on Luria- 
Bertani (LB) agar plates (at +4 
○
C). All cultures were subcultured monthly. 10 % LB 
glycerol stock was prepared for each strain and kept at -80°C. 
2.1.6. pGEM®-T Easy Cloning Vector 
pGEM®-T Easy Vector System that is supplied by Promega, is a convenient system 
for the cloning of PCR products. pGEM®-T Easy Vectors contains T7 and SP6 RNA 
polymerase promoters flanking a multiple cloning region within the α-peptide coding 
region of the enzyme β-galactosidase. pGEM®-T Easy Vector contains  multiple 
restriction sites within the multiple cloning region. The pGEM®-T Easy Vector 
multiple cloning region is flanked by recognition sites for the restriction enzymes 
EcoRI, BstZI and NotI. Therefore, this property provides three single-enzyme 
digestions for release of the insert. 
 
Figure 2.1: pGEM®-T Easy Vector circle map and sequence reference points. 
2.1.7. pMUTIN T3 Cloning Vector 
pMutin T3 is used for insertional gene inactivation in B. subtilis in order to 
characterize unknown open reading frames and to observe transcripional changes of 
constructed strains. This vector is a 8834 bp long plasmid and carries a reporter lacZ 
gene allowing to measure gene expression through β-galactosidase enzyme activity. 
Also pMUTIN T3 plasmid has an inducible promoter, Pspac, which is normally 
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suppressed by product of lacI gene, can be induced by IPTG at the same time.  
Besides, the plasmid carries amp and erm antibiotic resistance genes expressed in 
E.coli and B. subtilis, respectively.  
 
Figure 2.2:  Genomic map of pMUTIN T3 vector showing the restriction map and 
the functional genes. 
2.1.8. pDR66 Cloning Vector 
pDR66 is a 9,3 kb sized vector including cm resistance gene is used for co-
transformation of B. subtilis cell during transformation period to make easy selection 
of  transformants which have same antibiotic resistance gene with competent cell. 
 
Figure 2.3:   Schematic presentsation of pDR66 vector used for transformation due 
to Cat
R
 region facilitating the selection of mutant strains.  
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2.2. Methods 
2.2.1. DNA Techniques and Manipulation 
2.2.1.1. Plasmid DNA Isolation 
Qiagen Plasmid Purification Mini and Midi Kits (Qiagen Inc., Valencia, CA) were 
mostly used for isolation of E. coli plasmid DNA as specified by the manufacturers. 
Bacterial cells were harvested by centrifugation at 13.000 rpm for 5 minutes. After 
removing supernatant, the pellet was resuspended in 300 μl P1 buffer (Appendix B). 
The pellet an buffer mixed complately by vortexing. Following step, 300 μl P2  
(Appendix B) buffer was added and solution mix was then incubated at room 
temperature for 5 minutes. After this incubation, 300 μl P3 (Appendix B) buffer was 
added and mixed through inverting the tubes until the lysate is no longer viscous. 
The sample was incubated for 15 minutes on ice. Then centrifuged at 13.000 rpm for 
15 minutes. After that supernatant was transferred to a new clean 1.5 ml eppendorf 
tube.  Plasmid DNA was precipitated following the addition of 0,7 volume 
isopropanol and collected by centrifugation at 13.000 rpm for 30 minutes. Acquired 
pellet was washed with 1 ml of 70% ethanol. Ethanol was dried out of 37
 ◦
C for 15 
minutes after removing the supernatant completely. Finally, the pellet was dissolved 
in 15 μl elution buffer (EB) at 37◦C and 200 rpm, and stored at -20◦C. The isolated 
DNA was run on 1 % agarose gel. 
2.2.1.2. Chromosomal DNA Isolation 
Chromosomal DNA of B. subtilis strains was isolated and purified by using a 
standart procedure designed for Bacillus species (Cutting and Horn, 1990). 1.5 ml of 
overnight culture of Bacillus subtilis was harvested by centrifugation at 13000 rpm 
for 5 minutes. After discarding the supernatant obtained pellet was resuspended in 
567 μl of TE buffer (Appendix B) by repeated vortexing. 10 μl of proteinase K (20 
mg/ml), 6 μl of RNase (10 mg/ml), 24 μl of lysozyme (100 mg/ml) and 30 μl of 10% 
SDS were added one by one and well mixed solution mix was incubated for 1 hour at 
37°C in a water bath or in a thermomixer. Then, 100 μl of 5M NaCl solution was 
added and the sample was mixed by inverting the tubes without vortexing until  the 
mucosal white substance can be seen. After that, 80 μL of CTAB/NaCl  (Appendix 
B) (prewarmed to 65
o
C because of viscosity) solution was added into the mixture and 
it was incubated for 10 minutes in 65°C water bath or thermomixer. 
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Freshly prepared phenol/chloroform/isoamyl alcohol (25:24:1) was then added to the 
mixture with the same volume of solution for extraction and it was centrifuged at 
13000 rpm for 10 minutes. After centrifugation,  the upper phase was transferred to a 
new 1.5 ml microfuge tube and 0.7 volume isopropanol was added. After up-down 
for 5-6 times, the sample was centrifuged at 13000 rpm for 15 minutes. The 
supernatant was removed and the pellet was washed with 1 ml 70% ethanol and 
centrifuged at 13000 rpm for 5 minutes. Subsequently, the pellet was dried at 37°C 
for 1 hour and was dissolved in 10 μl of TE buffer. Obtained chromosomal DNA was 
stored at 4°C. Finally, the isolated DNA was made run on 0.8% agarose gel. 
2.2.1.3. Polymerase Chain Reaction (PCR) 
The oligonucleotide primers were purchased from OPERON, Co. (Table 2.2). PCR 
was performed using Taq polymerase 10x reaction buffer from Fermentas. All cycles 
lasted for 1 minute. The denaturation temperature was 94
o
C and the extention 
temperature was 72
o
C. The annealing temperature for the first 5 cycles was 50-55
o
C 
and 55-60
o
C for the next 25 cycles dependin on the primer. The concentration of 
chromosomal DNA was 0.01 to 0.001 ng/μl. The oligonucleotide primers were used 
at 1 - 10 pM (equimolar) and deoxyribonucleoside 5’triphosphates (dNTPs) were 
used at 2 mM final concentration. Oligonucleotide primers given in Table 2.2 used 
for confirmation of deletions. 
Table 2.2 : Oligunucleotide Primer Sequences 
Primer 
 
Oligunucleotide Primer Sequences 
ywfH HindIII 
Forward 
5’- GCA AGC TTT TTT CCC TCG TCA TTA ATT -3’ 
ywfH BamHI 
Reverse 
5’- GCG CAT CCC ATT CAT CAT ACT GTT TGT -3’ 
srfA Forward 5’-TAT TTG TAC AGG GTC CGC CG -3’ 
srfA  Reverse 5’- AAG CAG CTT CTC TTT CTC CGC -3’ 
phrC PstI  
Forward 
5’- GCC CTG CAG GCG GTC TCC ACA TTT GAA AGC -3’ 
phrC BamHI 
Reverse 
5’- CGG GGA TCC TAG  AAA GTA GGA AGC AGA CAG -3’ 
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A master mix composed of the materials listed below (Table 2.3) was prepared. 
Then, the master mix was divided into for each PCR tubes and 1 μl of chromosomal 
DNA of Bacillus subtilis PY79 was added into each tube as template DNA. Finally, 
0.5 μl of Taq polymerase was added for each tube. 
Table 2.3: List of materials used for preparation of PCR mixture 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.1.4. Agarose Gel Electrophoresis  
According to the purpose of electrophoresis, different concentration of agarose gels 
were used, which were given in Table 2.4. Electrophoresis was carried out on a 
horizontal submarine electrophoresis apparatus and in a gel system composed of  
~1%  agarose gel (different gel concentration for different samples) (Table 2.4) 
containing 1xTAE buffer (Appendix B) and ethidium bromide of a 0.2 μg/mL 
finalconcentration. 6X Loading dye was added into the samples. Electrophoresis was 
performed at 90-120 Volts for 20-30 minutes. The DNA bands were visualized on a 
shortwave UV transilluminator (UVP) and photographed by using Gel Imaging 
System. EcoRI+HindIII digested DNA marker and HinfI digested DNA Marker 
(Appendix D) were used to determine the molecular weights of DNA bands for 
desired purposes.  
Content of PCR mixture Amount 
Reverse primer         1 μl 
Forward primer 1 μl 
10x Buffer (-MgCl2)             1 μl 
 MgCl2                                            5 μl 
 dNTP Mix (2 mM)               5 μl 
Template DNA 1 μl 
Taq polymerase 0,5 μl 
 dH2O                                  35,5 μl 
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Table 2.4 : Agarose gel concentration for different samples. 
 
 
 
 
2.2.1.5. Gel Extraction 
 The desired fragments were extracted from the gel by using a Qiaquick Gel 
Extraction kit (Qiagen Inc., Valencia, CA). The gel slice containing the DNA band 
was cut off from the gel and DNA extraction from gel was performed according to 
the Qiagen’s instructions. After obtaining DNA, an aliquot was run on agarose gel to 
monitor the final DNA concentration. 
2.2.1.6. Ligation of PCR Products into pGEM®-T Easy Vector 
Ligation of PCR products to pGEM®-T Easy Vector was performed as follows: 5 μl 
2X Rapid Ligation Buffer, T4 DNA Ligase, 1 μl (50 ng/μl) pGEM®-T Easy Vector, 
2 μl insert DNA (PCR product) and 2 μl dH2O was added and total volume was 
completed to 10 μl. Reaction mixture was incubated overnight at 4◦C. After ligation 
was completed, the mixture was used for transformation into E. coli Top10F’. 
2.2.1.7. Ligation of pMutinT3 Vector 
Ligation procedure for cloning into the pMutinT3 vector was carried out using 9.5 μl 
of ywfH PCR products as insert fragments and 0.5 μl of pMutinT3 vector. Vector and 
fragment were mixed in a clean eppendorf tube and incubated for 5 min at 65°C. 
Then, the tube was cooled on ice. Following cooling step, 2 μl of ligation 10x buffer, 
2 μl of Polyethylene glycol (50% PEG 8000), 2 μl of T4 DNA ligase, 4 μl of dH2O 
were added into the same eppendorf tube. In last step, the mixture was again 
centrifuged for a short spin and incubated at 16°C for 16 h. 
2.2.1.8. Restriction Enzyme Digestion 
Digestion reactions were carried out in a way that the amount of 10X digestion 
buffer was 1/10 of the total reaction mix. The reaction mix was incubated for 1-4 
hours at 37°C, then enzyme denaturation at 65°C for 10 minutes. The sample was 
stored at -20
o
C. 
                 Sample Concentration 
Chromosomal DNA 0,8 % 
Plasmid DNA 1 % 
Digestion products of plasmid 1 % 
PCR products with  1.5 % - 2 % 
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2.2.2. Transformation 
2.2.2.1. Preparation of E.coli Electrocompetent Cells and Transformation of 
Electrocompetent E.coli Top10F’ Cells 
The overnight culture of E.coli Top10F’ was diluted 1:100 fold into 400 ml 2xYT 
medium which contained Tetracyclin (20 μg/ml). Then incubated at 37
 o
C with 250 
rpm by shaking until reached to 0.6 of OD600 (Optical Density at 600 nm). After that 
incubated cells were stayed on ice for 30 minutes. Cells were harvested by 
centrifugation at 5000 rpm for 5 minutes. After removal of supernatant, pellet was 
resuspended in 40 ml of cold distilled water and centrifuged at 5000 rpm for 15 
minutes. Supernatant was discard and pellet was resuspended in 20 ml cold distilled 
water and centrifuged at 5000 rpm for 15 minutes again. After this step, supernatant 
was discarded and pellet was resuspended in 1 ml of cold steril 10 % glycerol. 
Finally, it was dispensed into aliquots of 40 μl into eppendorf tubes. These aliquots 
were frozen immediately by immersing within liquid nitrogen and stored at -80
 o
C. 
For transformation, competent E. coli cells were incubated on ice shortly. 10 μl of 
ligation products or 0.5 μg of appropriate plasmid DNA was added into the tube of 
competent cell and were mixed gently by help of finger. Then, mix was transferred 
into pre-cold electroporation tube. The sample was placed onto electroporator and 
the process was carried out at 1800V. After addition of 1ml LB broth into the 
mixture, it was transferred into a 2 ml eppendorf tube. Incubation was made at 37
o
C 
for 60 minutes by shaking at 200 rpm. After incubation, the cells were centrifuged at 
5000 rpm for 10 min and supernatant was discarded. Obtained pellet was 
resuspended in 100 μl 8.5 % saline solution (NaCl) (Apendix B). Transformed cells 
were plated on selective medium containing appropriate antibiotic (100μg/ml 
ampicillin). For the purpose of blue-white colony selection, they were plated on LB 
agar media containing 40 mg/ml X-gal, 1 mM IPTG and 100μg/mL ampicillin. 
2.2.2.2. Preparation of B. subtilis Competent Cells and Transformation 
Preparation of B. subtilis competent cells and transformation were performed as 
described by Klein et al. (1992). HS and LS (Appendix B) mediums were used for 
the preparation of B. subtilis competent cells. Appropriate amount of B. subtilis cells 
were inoculated into 3 ml of HS medium and it was cultured overnight at 37°C by 
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shaking at 250 rpm. 0,5 ml of this overnight culture was transformed into 20 ml of 
freshly prepared LS medium and incubated at 30°C by shaking at 200 rpm until 
OD600  reached to 0,55. Then, 1 ml of competent cells was transferred into 2 ml 
eppendorf tube in which contained 1 μl of chromosomal DNA or suitable plasmid 
was added. The cells were then incubated at 37°C for 2 hours by shaking at 200 rpm 
and incubated cells were harvested by centrifugation at 5000 rpm for 10 minutes. 
Finally, the pellet was resuspended in 100 μl of sterile saline solution and was spread 
out on LB agar plates containing selective antibiotic and incubated at 37°C for 16 h. 
2.2.2.3. The Selection by MLS Resistance Method 
Competent B. subtilis cells were incubated in HS medium until reached to 0.55 of 
OD600 by the same conditions given the Section 2.2.2.2 and then incubated for 2 
hours. In the overlay step, firstly, 2 μl of 2 mg/ml erythromycin (erm) antibiotic 
solution was added into a small test tube containing 2,5 ml % 0.7 LB agar which was 
melted and kept in 50°C. Then, immediately, all amount of transformed cells were 
added into same tube, mixed quickly and were poured onto an antibiotic-free LB 
agar plate containing 25 ml LB agar. Following incubation at 37°C for 2 hours, a 
second overlay was performed. This second overlay has contained 2.5 ml of melted 
% 0.7 LB agar, 20 μl (2 mg/ml) erythromycin antibiotic solution and 20 μl (50 
mg/ml) lincomycin antibiotic solution. The agar plate was incubated at 37°C for 1-2 
days. 
2.3. Beta-Galactosidase Activity Assay 
Initially, all strains were grown overnight at 37°C in PA medium (Appendix A). 
Then, they were used to inoculate 100 ml of PA medium to an initial optical density 
of about 0.1 at 595 nm (OD595). The cultures were incubated at 37°C shaking at 250 
rpm for 30 h. 1 ml of culture was collected as double eppendorf tubes for each hour 
for checking up of assay. Suitable dilution was made for measurement, if needed.  
After each sampling, the culture was centrifuged at 13000 rpm for 5 minutes and the 
supernatant was discarded. Then, the pellet was washed with 500 μl of ice-cold 25 
mM Tris-Cl (pH 7.4) by centrifugation. Following, the removal of the supernatant, 
the pellet was resuspended in 640 μl Z-buffer by vortex and 160 μl of lysozyme was 
added. Later, the solution was vortexed for a second and incubated at 37°C for 5 min. 
Subsequently, the samples were taken on ice and 8 μl of 10% Triton-X100 was 
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added. After vortexing for a while, the extracts were stored on ice until performing β-
galactosidase assay.  
β-galactosidase assay was executed in the first place by prewarming the extracts in 
30°C water bath for 5 min. Subsequent to this, 200 μl of ONPG solution was added 
and the solution was watched for the progression of the yellow color. Following, the 
reaction was stopped by the addition of 1 M Na2CO3 and reaction time was recorded. 
Reaction time refers to a period that was started by adding ONPG and continued 
until formation of the yellow color, and so this period was recorded. At last, the 
samples were centrifuged at 13000 rpm for 5 min. and the supernatant was taken to 
measure OD at  A420 and A550. Calculations for β-galactosidase activity were carried 
out according to the formulation (Miller, 1972) below and a graph for both the β-
galactosidase activity and log OD595 was drawn.      
    
                                    A420 – (1.75 x A550 )  
Miller units =   --------------------------------------    x 1000                                    (2.1) 
                              Reaction time (min) x OD595    
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3.  RESULTS AND DISCUSSION 
3.1 Construction of ywfH Insertional Plasmid 
For integration of pMUTIN T3 vector, as first step, a ywfH gene fragment, 394 bp in 
lenght, was amplified by PCR using chromosomal DNA of Bacillus subtilis PY79 
wild type strain as the template DNA. The primers ywfH Forward  5’- 
GCAAGCTTTTTTCCCTCGTCATTAATT -3’ and ywfH Reverse 5’- 
GCGGATCCCATTCATCATACTGTTTGT -3’ containing extra residues including 
HindIII and BamHI site at their 5′ ends (underlined residues) were used for a partial 
394 bp gene fragment amplification of 777 bp ywfH gene. Hence, a total of 394 bp 
amplified gene fragment was obtained by PCR (Fig. 3.1). 
The amplified PCR product was purified after running on agarose gel. Extracted 
fragment was ligated into pGEM®-T Easy Cloning Vector (Promega) and used for 
the transformation of E. coli Top10F’ electro-competent cells. Suitable plasmid 
carrying 394 bp insert within pGEM®-T Easy Cloning Vector was selected and the 
sequence analysis was performed. Nucleotide sequence result of sequence analysis 
data was compared to B. subtilis genome sequence, using BLAST search, at National 
Center for Biotechnology Information (NCBI) database for further confirmation. 
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Figure 3.1:   1-2; PCR products of 394 bp ywfH gene fragment amplified with   
specific primers ywfH F and ywfH R, 3; Negative control of PCR and M; Marker 10: 
ΦX174 DNA / HinfI (Appendix D). 
This recombinant pGEM®-T Easy Vector was firstly digested only with EcoRI in 
order to take out the fragment which included ywfH fragment and was run on agarose 
jel (Fig 3.2).  
 
Figure 3.2:   Fragment obtained from EcoRI digestion of the recombinant pGEM®-                     
T Easy Vector, including ywfH gene fragment and M; Marker 10: ΦX174 DNA / 
HinfI (Appendix D). 
Then, ywfH gene fragment from pGEM®-T Easy recombinant vector and pMUTIN 
T3 vector were both digested with HindIII and BamHI restriction enzymes. 
Following that digested ywfH fragment from pGEM®-T Easy and digested pMUTIN 
T3 were extracted from agarose gel and they were ligated with T4 ligase overnight at 
4
o
C. After the transformation E. coli Top10F’ competent cells with this ligation 
product, transformants were selected on 100 μg/ml ampicillin containing agar plates. 
Plasmid DNAs were isolated from the selected colonies, subsequently linearized and 
run on agarose gel in order to verify the expected size (9359 bp). Then, suitable sized 
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plasmids were selected and digested with HindIII and BamHI restriction enzymes for 
confirmation of the existance of ywfH fragment in the pMUTIN T3 vector.  
 3.2. Construction of ywfH::lacZ Transcriptional Fusion in B. subtilis  
The selected recombinant pMUTIN T3 plasmid carrying 394 bp ywfH fragment was 
used to transform B. subtilis PY79 wild type strain in order to construct 
ywfH::lacZ::erm transcriptional fusion in its chromosome. This integration, also 
called Campbell-like insertion, was a result of a single cross-over event at ywfH 
region.  
The selection based on the erythromycin resistance on LB plates containing 
erythromycin (1μg/mL) could not be fully performed because of the generation of the 
spontaneous erythromycin resistant B. subtilis PY79 cells. To eliminate this problem, 
an alternative selection method, Macrolide-Lincosamide-Streptogramin B-resistance 
(MLS
R
) conferred by erm gene, was used. Chromosomal DNA of the resultant MLS
R
 
transformant was isolated and screened through PCR analysis by using primers 
specific to erm resistance gene on pMUTIN T3 in order to confirm the insertion of 
the plasmid into the B. subtilis chromosome. 703 bp erm gene was amplified by 
using the chromosomal DNA of MLS
R
 B. subtilis transformants as template (Fig 
3.3). The corresponding MLS
R 
B. subtilis PY79 transformant was designated as 
NAO1. 
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Figure 3.3: The confirmation of ywfH::lacZ::erm in B. subtilis chromosome. 1: 
PCR reaction with primers specific to ywfH gene by using Bacillus subtilis PY79 
genomic DNA as positive control; 2-3: PCR product amplified with specific primers 
to ywfH gene using chromosomal DNA of ywfH::lacZ::erm mutant as template; 4: 
Negative control for  PCR product of ywfH gene  5-6: PCR product amplified with 
specific primers to within pMutinT3 vector using chromosomal DNA of 
ywfH::lacZ::erm mutant as template; 7: Negative control for  PCR product of erm 
resistance gene; M: Marker 3: Lambda DNA / EcoRI+HindIII (Appendix D). 
3.3. Expression of Transcriptional ywfH::lacZ Fusion in PA Medium 
In order to compare the expression level of ywfH both in ywfH::lacZ mutant strain 
NAO1 and wild type B. subtilis PY79, cells were grown in PA medium, which is a 
defined medium that stimulates bacilysin production, at 37
o
C and 200 rpm. Samples 
for this culture were collected at 1 hour interval for thirty hours, and growth of cells 
was monitored. Collected cells were assayed for their β-galactosidase activity, using 
ONPG as substrate and enzyme activity was explored in Miller units. The results of 
expression of ywfH::lacZ fusion and B. subtilis PY79 wild type strain were compared 
as can be seen in the Figure 3.5.  Growth profiles of both strains were similar (Figure 
3.4). Expression of ywfH in NAO1 mutant strain was observed to be increased in the 
exponential phase slowly, then was increased in the transition state between 
exponential and stationary phase and reached to its maximal level (detected as 86 
Miller units) upon entry into stationary phase. (Figure 3.4).  
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Figure 3.4: Growth profiles of B. subtilis PY79 and NAO1 (ywfH::lacZ::erm) 
strains grown in PA medium. The symbols used for the strains are; (●) PY79 (wild 
type) and (♦) NAO1 (ywfH::lacZ::erm). 
 
Figure 3.5:  β-Galactosidase activities of B. subtilis PY79 and NAO1 
(ywfH::lacZ::erm) strains grown in PA medium. Specific Miller Units were 
calculated using the formula as denoted in Section 2.3. The symbols used for the 
strains are; (●) PY79 (wild type) and (♦) NAO1 (ywfH::lacZ::erm). 
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3.4. Deletion of regulatory Genes and Their Effects on the Expression of ywfH 
gene in B. subtilis 
3.4.1. Deletion of srfA Gene and Its Effect on the Expression of ywfH Gene in  
Bacillus subtilis 
srfA operon is consisted of four genes (srfAA, srfAB, srfAC, srfAD) and is necessarily 
needed for the efficient development of genetic competence which is regulated by 
ComA response regulatory protein. srfA contains the competence regulatory gene 
comS which is nested within and out of frame with the second gene of the operon, 
srfAB.  Furthermore, ComS is essential for competence to develop. The srfA operon 
is normally expressed during active growth at a low level, however, just before the 
transition to stationary phase, its transcription is increased sharply dependent on 
comA, spo0K  and comQ activity. Phosphorylation of ComA stimulates the binding 
of ComA~P to the srfA promoter, and as such induces srfA transcription and 
surfactin production. Also null mutations of those three genes resulted in a decrease 
of the expression level of srfA (Roggiani & Dubnau, 1993; Cosby et al., 1998; 
Hamoen et al., 2003; van Sinderen et al., 1990, Hahn and Dubnau, 1991).  
In order to monitor the effect of srfA gene deletion on ywfH profile, srfA gene was 
deleted in the ywfH::lacZ fusion strain NAO1. NAO1 that was used as competent 
cell, was co-transformed by the chromosomal DNA of ∆srfA::erm comS derivative 
strain, KE10 and pDR66 plasmid DNA. Both NAO1 and KE10 had erm antibiotic 
resistance so using pDR66 made selection of tranformants easier considering the 
advantage of its cat antibiotic cassette region. Selection of transformants on LB agar 
plates was performed with Erm(1μg/ml), Ln (25μg/ml) and Cat (20 μg/ml) 
antibiotics and then transformants were screened with PCR using specific primers. 
Selected mutant was named as NAO18 (∆srfA::erm  ywfH::lacZ::erm).  
The resulting strain NAO18 and NAO1 as control, were cultured in PA medium and 
were sampled in every 1 h period for the β-galactosidase assay. Growth profiles were 
shown in Figure 3.6 and β-galactosidase activities were shown in the Figure 3.7.  
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Figure 3.6: Growth profile of NAO18 (∆srfA::erm ywfH::lacZ::erm) and 
NAO1(ywfH::lacZ::erm) strains grown in PA medium. The symbols used for the 
strains are; (●)NAO18 (∆srfA::erm ywfH::lacZ::erm) and (♦) NAO1 
(ywfH::lacZ::erm). 
 
Figure 3.7:  β-Galactosidase activities of NAO18 (∆srfA::erm ywfH::lacZ::erm) 
and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. Specific Miller Units 
was calculated with formula as denoted in Section 2.3. The symbols used for the 
strains are; (●)NAO18 (∆srfA::erm ywfH::lacZ::erm) and (♦) NAO1 
(ywfH::lacZ::erm). 
Figure 3.7 points out that deletion of srfA gene dramatically disrupted ywfH gene 
expression. Previous data indicated that srf operon might be an intermediate 
component of the regulatory pathway and also proposed that srfA gene products act 
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in B.subtilis cell specialization and differentiation (Hahn and Dubnau, 1991; Nakano 
et al., 1991).  It was previously shown that srfA disturbed mutants were not able to 
produce bacilysin, so srfA might be effective on biosynthesis of bacilysin (Karataş et 
al., 2003). In this present study, it was suggested that the disruption of srfA gene 
might seriously effect bacilysin production via effecting the expression of ywfH gene 
negatively.  
3.4.2 Deletion of oppA Gene and Its Effect on the Expression of ywfH gene in B. 
subtilis 
Oligopeptide permeases are needed for bacteria to utilize peptides as nutrient sources 
(Solomon et al., 2003). B. subtilis opp operon encodes five proteins—OppA, OppB, 
OppC, OppD, and OppF. OppA binds to the peptide substrate and facilitates its 
uptake by interacting with and delivering the peptide to the OppBCDF complex. opp 
was first identified as a sporulation operon, named spo0KABCD.  In CSF pathway, 
the Opp component plays a key role in the peptide export-import circuit which 
coordinates timing of competence and sporulation events. Mutations in oppA, oppB, 
oppC, and oppD completely block the ability for oligopeptides uptake into cell 
(Perego et al., 1991; Perego 1997; Rudner et al., 1991; ). 
To monitor the deletion effect of oppA gene on ywfH expression, oppA gene was 
deleted in NAO1 by transforming NAO1 competent cells by the chromosomal DNA 
of oppA::Tn10::spc mutant strain, AK3. Then selection of transformants on LB agar 
plate containing Spc (100μg/ml) was performed. Selected mutant was named as 
NAO15 (oppA::Tn10::spc ywfH::lacZ::erm). 
The resulting strain NAO15 and NAO1 as control, were cultured in PA medium and 
were sampled at 1 h period for the β-galactosidase assay. Growth profiles were 
shown in Figure 3.18 and β-galactosidase activities were shown in the Figure 3.9. 
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Figure 3.8:  Growth profile of NAO15 (oppA::Tn10::spc ywfH::lacZ::erm) and 
NAO1 (ywfH::lacZ::erm) strains grown in PA medium. The symbols used for the 
strains are; (●) NAO15 (oppA::Tn10::spc ywfH::lacZ::erm) and (♦) NAO1 
(ywfH::lacZ::erm). 
 
 
Figure 3.9:  β-Galactosidase activities of NAO15 (oppA::Tn10::spc 
ywfH::lacZ::erm) and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. 
Specific Miller Units was calculated with formula as denoted in Section 2.3. The 
symbols used for the strains are;(●)NAO15 (oppA::Tn10::spc ywfH::lacZ::erm) and 
(♦)NAO1 (ywfH::lacZ::erm). 
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Figure 3.9 shows that ywfH::lacZ expression was severely disrupted in the absence of 
oppA gene product both during exponential and stationary phases. Yazgan et al. (in 
2001) reported that oppA mutation created a loss of  bacilysin biosynthesis and 
therefore, it was suggested that bacilysin biosynthesis is under the global quorum 
sensing mechanism or a component of this mechanism. (Yazgan et al., 2001). In this 
study, ywfH expression was shown to be regulated crucially with oppA, as a probable 
part of quorum sensing mechanism. 
3.4.3. Deletion of Phr Peptides Genes (phrC, phrK, phrF) and Their Effects on 
the Expression of  ywfH gene  in B. subtilis 
B. subtilis encodes a family of 8 Phr peptides (PhrA, PhrC, PhrE, PhrF, PhrG, PhrH, 
PhrI, and PhrK) and a family of 11 Rap proteins (RapA to RapK) (Table 1.1). Each 
Phr peptide is encoded together with its cognate Rap protein from an unique operon, 
and each characterized Phr inhibits the activity of its Rap protein. Very recently, it 
was shown that ComA-dependent gene expression is stimulated by Phr peptides 
including PhrC, PhrF and PhrK and that all three peptides are required for full 
expression of ComA-dependent genes (Auchtung et al., 2006).  
Under the light of the finding that opp deletion resulted in complete repression of 
ywfH expression, Opp-imported pheromones PhrF and PhrK as well as PhrC are 
considered to have function in ywfH expression and thus the expression of 
ywfH::lacZ expression was examined in the PhrC, PhrF and PhrK mutant 
backgrounds.  
Therefore, in order to monitor the effects of blockage of phrC,  phrK, and  phrF 
genes on  ywfH::lacZ fusion, mutant strain NAO12 (∆phrC::erm ywfH::lacZ::erm),  
NAO14 (∆phrK::spc ywfH::lacZ::erm) and NAO13 (∆phrF163::cat 
ywfH::lacZ::erm)   mutant strains were constructed separately. Transformation of 
NAO1 mutant strain with CAL7 (∆phrK7::spc) and JMA163 (∆phrF163::cat) 
chromosomal DNAs, respectively. Only for deletion of phrC gene in NAO1 
(ywfH::lacZ::erm), the competent cells of JMS751 (∆phrC::erm) supplied from A.D. 
Grossman,  was co-transformed with chromosomal DNA of NAO1 and pDR66 
plasmid and selection was made depending on the resistance to Erm(1μg/ml), Ln 
(25μg/ml) and Cat (20 μg/ml) antibiotics.  
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One of the transformants was selected and named as NAO12 (ywfH::lacZ::erm 
∆phrC::erm). Moreover, phrC deletion mutations were confirmed by PCR analysis 
using specific primers (Table 2.2). Other resulting strains were named as NAO14 
(∆phrK::spc ywfH::lacZ::erm) and  NAO13 (∆phrF163::cat ywfH::lacZ::erm) 
mutant strains. The resulting strains NAO12, NAO14, NAO13 and NAO1, as 
control, were cultured in PA medium and the specific activities of the samples were 
measured. Also growth profile of mutants was followed (Fig. 3.10, 3.11, 3.12, 3.13). 
 
 
Figure 3.10:  Growth profile of NAO12 (ywfH::lacZ::erm ∆phrC::erm), NAO13 
(∆phrF163::cat ywfH::lacZ::erm), NAO14 (∆phrK::spc ywfH::lacZ::erm) and 
NAO1 (ywfH::lacZ::erm) strains grown in PA medium. The symbols used for the 
strains are; (▲)NAO12 (ywfH::lacZ::erm ∆phrC::erm); (●)NAO14 (∆phrK::spc 
ywfH::lacZ::erm); (■)NAO13 (∆phrF163::cat ywfH::lacZ::erm) and (♦) NAO1 
(ywfH::lacZ::erm). 
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Figure 3.11: β-Galactosidase activities of NAO12 (ywfH::lacZ::erm ∆phrC::erm) 
and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. Specific Miller Units 
was calculated with formula as denoted in Section 2.3. The symbols used for the 
strains are; (▲) NAO12 (ywfH::lacZ::erm ∆phrC::erm) and (♦)NAO1 
(ywfH::lacZ::erm). 
 
 
Figure 3.12: β-Galactosidase activities of NAO14 (∆phrK::spc ywfH::lacZ::erm)  
and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. Specific Miller Units 
was calculated with formula as denoted in Section 2.3. The symbols used for the 
strains are; (●)NAO14 (∆phrK::spc ywfH::lacZ::erm) and (♦)NAO1 
(ywfH::lacZ::erm). 
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Figure 3.13: β-Galactosidase activities of  NAO13 (∆phrF163::cat   
ywfH::lacZ::erm) and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. 
Specific Miller Units was calculated with formula as denoted in Section 2.3. The 
symbols used for the strains are; (■) NAO13 (∆phrF163::cat ywfH::lacZ::erm) and 
(♦) NAO1 (ywfH::lacZ::erm). 
As seen in Figure 3.11, Figure 3.12 and Figure 3.13 the deletion mutation of phrC, 
phrF and phrK genes affected ywfH::lacZ expression severely. Therefore, results in 
this present study shows that the PhrC, PhrF and PhrK peptides are required for the 
regulation of ywfH expression by enhancing the full activation of transcriptional 
factor ComA~P in bacilysin biosynthesis. 
3.4.4 Deletion of comQ(comX), comP, comA and spo0H and Their Effects on the 
Expression of ywfH gene in B. subtilis 
Genes of a two-component regulatory system, comA and comP are located at 
downstream of comX gene the on the chromosome of B. subtilis. The upstream gene 
comQ is needed for producing a modified peptide pheromone in the system. The 
ComQ-ComX–ComP–ComA signaling pathway controls the quorum response in B. 
subtilis. (Griffith and Grossman, 2008; Kleerebezem et al., 1997; Weinrauch et al., 
1990). 
ComX, which is a major extracellular signaling peptide, binds to its cognate receptor 
kinase, ComP, resulting in autophosphorylation of ComP at a conserved histidine 
residue. Then, phosphorylated ComP donates phosphate to its cognate response 
regulator, ComA, on a conserved aspartate residue. Once phosphorylated, ComA~P 
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functions to activate transcription of target genes such as srfA, degQ, rapA and rapC 
(Solomon et al.,1995 and 1996; Msadek et al., 1999; Griffith and Grossman, 2008). 
spo0H gene which encodes σH, is involved in many cellular responses. The 
transcription of phrC is partly controlled via sigma factor σH dependent promoter 
(P2) located at upstream of phrC and internal to rapC. Defects in production of some 
of signaling peptides in spo0H mutants are indicated that several cellular responses 
are modulated by population density and by controlling effect of sigma H on the 
expression of the phr genes by sensing extracellular peptides (Rudner et al., 1991; 
Ireton et al., 1993; Lazazzera et al., 1997; McQuade et al., 2001). Beside the role of 
σH in phrC transcription, it is indicated that it has at least one other role in production 
of CSF. Therefore, σH, respectively, play a key role in the initiation of sporulation 
(Lazazzera et al., 1999). 
The effects of comQ, comP, comA and spo0H genes on ywfH expression were 
monitored. For this  purpose, comQ, comP, comA and spo0H genes were 
insertionally deleted in NAO1 that was used as competent cell and transformed by 
JMS315 (trpC2 pheA1 ∆comQ::spc), BD1658 (∆comP::spc), JRL192 (∆comA::cat) 
and JMS175(∆spo0A::spc) chromosomal DNAs respectively. Resulting 
transformants were named as NAO11 (∆comQ::cat ywfH::lacZ::erm), NAO10 
(∆comP::spc  ywfH::lacZ::erm), NAO9 (∆comA::cat  ywfH::lacZ::erm) and NAO4 
(∆spo0H::spc  ywfH::lacZ::erm). 
The resulting strains NAO11, NAO10, NAO9, NAO4 and NAO1, as control, were 
cultured in PA medium and the specific activities of the samples were measured. 
Also growth of mutants was followed (Fig. 3.14, 3.15, 3.16, 3.17, 3.18). 
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Figure 3.14:  Growth profile of NAO11 (∆comQ::cat ywfH::lacZ::erm), NAO10 
(∆comP::spc ywfH::lacZ::erm), NAO9 (∆comA::cat ywfH::lacZ::erm), NAO4 
(∆spo0H::spc  ywfH::lacZ::erm) and NAO1 (ywfH::lacZ::erm) strains grown in PA 
medium. The symbols used for the strains are; (▲) NAO11 (∆comQ::cat 
ywfH::lacZ::erm); (●) NAO10 (∆comP::spc  ywfH::lacZ::erm); (■) NAO9 
(∆comA::cat ywfH::lacZ::erm); (*) NAO4 (∆spo0H::spc  ywfH::lacZ::erm) and   (♦) 
NAO1 (ywfH::lacZ::erm). 
 
 
Figure 3.15:  β-Galactosidase activities of NAO11 (∆comQ::cat ywfH::lacZ::erm) 
and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. Specific Miller Units 
was calculated with formula as denoted in Section 2.3. The symbols used for the 
strains are; (▲) NAO11 (∆comQ::cat ywfH::lacZ::erm) and (♦) NAO1 
(ywfH::lacZ::erm). 
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Figure 3.16:   β-Galactosidase activities of NAO10 (∆comP::spc ywfH::lacZ::erm) 
and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. Specific Miller Units 
was calculated with formula as denoted in Section 2.3. The symbols used for the 
strains are; (●) NAO10 (∆comP::spc  ywfH::lacZ::erm) and (♦) NAO1 
(ywfH::lacZ::erm). 
 
 
Figure 3.17:  β-Galactosidase activities of NAO9 (∆comA::cat ywfH::lacZ::erm) 
and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. Specific Miller Units 
was calculated with formula as denoted in Section 2.3. The symbols used for the 
strains are; (■) NAO9 (∆comA::cat ywfH::lacZ::erm) and (♦) NAO1 
(ywfH::lacZ::erm). 
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Figure 3.18:  β-Galactosidase activities of NAO4 (∆spo0H::spc  ywfH::lacZ::erm)  
and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. Specific Miller Units 
was calculated with formula as denoted in Section 2.3. The symbols used for the 
strains are; (*) NAO4 (∆spo0H::spc  ywfH::lacZ::erm) and (♦) NAO1 
(ywfH::lacZ::erm). 
 
As shown in Figure 3.15, 3.16, 3.17, 3.18,  the expression of ywfH was impaired 
completely in case of the deletion of comA, comP, comQ and spo0H genes. ComP 
and ComX(ComQ) were required for signal transduction system that activate ComA 
and also σH required for phr gene expression during transition state initiating signal 
transduction cascade for ComA~P-dependent gene expression as quorum response. 
A former study also indicated that inactivation of spo0H gene in the strain PY79 
resulted in the loss of bacilysin biosynthetic ability (Karataş et al., 2003). It can be 
suggested that the expression of ywfH gene regulation might be ComA-dependent. 
Therefore, ComA, ComP, ComQ and σH can regulate biosynthesis of bacilysin by 
effecting the expression of ywfH gene.  
3.4.5 The Effects spo0A and abrB Null Mutations on the Expression of ywfH 
gene in B. subtilis 
Spo0A is a classical two domain response regulator that is required for initiation of 
sporulation in Bacillus subtilis. After activation, Spo0A can act as both a 
transcription repressor and a transcription activator (Seredick and Spiegelman, 2007). 
On the other hand, additional genes involved in production of mature CSF is 
probably also controlled by spo0A and abrB. These genes have much greater effects 
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on accumulation of extracellular CSF than transcription of phrC ( Lazazzera et al., 
1999).  
AbrB represses many stationary phase processes in Bacillus subtilis. Especially 
genes involved in sporulation (e.g. spo0E, spoVG), degradative enzyme synthesis 
(e.g. aprE), amino acid utilization (e.g. dpp), and antibiotic production (e.g. tycA) . 
The presence of AbrB during exponential growth prevents premature expression of 
these genes.  
Expression of abrB declines as a result of transcriptional repression by the activated 
response regulator Spo0A towards the end of exponential growth. Moreover, in the 
absence of Spo0A, AbrB becomes overproduced, and the expression of many 
stationary phase genes, among which found competence genes, is inhibited (Hamoen 
et al., 2003). 
To monitor the effects of spo0A and abrB null mutations on ywfH expression, spo0A 
and abrB genes were inactivated in NAO1. For this purpose, firstly, NAO1 
competent cells were used for the transformation of chromosomal DNAs of BAL373 
(trpC2 pheA1 ∆abrB::cat) and JMS175 (∆spo0A::spc) mutant derivatives. The 
selected mutants with regard to specific antibiotic resistance were named as NAO5 
(∆abrB::cat ywfH::lacZ::erm), NAO3 (∆spo0A::spc ywfH::lacZ::erm) and NAO7 
(∆spo0A::spc ∆abrB::cat ywfH::lacZ::erm). The expression of ywfH::lacZ fusion 
was analyzed in spo0A-abrB double mutant genetic background for detection of the 
effect of absence of both repressor proteins that repress different genes in sequential 
stages. spo0A-abrB double mutant strain NAO7 (∆spo0A::spc ∆abrB::cat 
ywfH::lacZ::erm) was constructed by transforming NAO5 (∆abrB::cat 
ywfH::lacZ::erm) competent cells with the chromosomal DNA of  JMS175 
(∆spo0A::spc). Transformants were selected on agar plates containing antibiotics Cat 
(20 μg/ml) and Spc (100μg/ml). In addition step, this double mutant strain (NAO7) 
was performed on DSM (Appendix A) agar plate in order to detect sporulation 
ability. 
The resulting strains NAO5, NAO3, NAO7, and NAO1, as control, were cultured in 
PA medium and the specific activities of the samples were measured. Growth profile 
of mutants was also followed (Fig. 3.19, 3.20, 3.21, 3.22). 
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Figure 3.19:  Growth profile of  NAO5 (∆abrB::cat  ywfH::lacZ::erm),  NAO3 
(∆spo0A::spc ywfH::lacZ::erm), NAO7 (∆spo0A::spc ∆abrB::cat ywfH::lacZ::erm) 
and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. The symbols used for the 
strains are; (▲) NAO7 (∆spo0A::spc ∆abrB::cat ywfH::lacZ::erm); (●)NAO3 
(∆spo0A::spc ywfH::lacZ::erm); (■) NAO5 (∆abrB::cat ywfH::lacZ::erm); (♦) 
NAO1 (ywfH::lacZ::erm). 
 
 
 
Figure 3.20:  β-Galactosidase activities of NAO5 (∆abrB::cat  ywfH::lacZ::erm)  
and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. Specific Miller Units 
was calculated with formula as denoted in Section 2.3. The symbols used for the 
strains are; (■)NAO5 (∆abrB::cat  ywfH::lacZ::erm) and (♦) NAO1 
(ywfH::lacZ::erm). 
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Figure 3.21: β-Galactosidase activities of NAO3 (∆spo0A::spc ywfH::lacZ::erm)  
and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. Specific Miller Units 
was calculated with formula as denoted in Section 2.3. The symbols used for the 
strains are; (●)NAO3 (∆spo0A::spc ywfH::lacZ::erm) and (♦) NAO1 
(ywfH::lacZ::erm). 
 
 
Figure 3.22:  β-Galactosidase activities of NAO7 (∆spo0A::spc ∆abrB::cat   
ywfH::lacZ::erm)   and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. 
Specific Miller Units was calculated with formula as denoted in Section 2.3. The 
symbols used for the strains are; (▲) NAO7 (∆spo0A::spc ∆abrB::cat 
ywfH::lacZ::erm) and (♦) NAO1 (ywfH::lacZ::erm). 
As seen in abrB null mutation, in stationary phase, the expression of ywfH::lacZ was 
not severely repressed, there was only a decrease from 197 to 148 Spesific Miller 
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Units (Figure 3.20). As shown in Fig. 3.21 the expression of ywfH::lacZ was fully 
eliminated by deletion of spo0A gene. Former studies also showed that spo0A, spo0B 
and spo0H null mutants were unable to synthesize bacilysin. Also spo0A defected 
mutants of Bacillus subtilis were deficient in the synthesis of many antimicrobials 
and in resistance to a number of antibiotics (Yazgan et al., 2001; Strauch, 1993; 
Trowsdale et al., 1978). Therefore, this present study pointed that spo0A gene was 
dramatically necessary for ywfH gene expression. On the other hand, in case of 
double mutant, it was seen that disappeared ywfH expression was partially relieved 
by the null mutation of abrB which was observed in Figure 3.22. Additionally, the 
presence of AbrB during exponential growth prevents premature expression of genes 
in antibiotic production (Hamoen et al., 2003). Consistently,  the expression of ywfH 
gene increased during exponential phase in the absence of AbrB. Indicated that ywfH 
expression is repressed by abrB during exponential phase (Figure 3.22). This present 
study also showed that both AbrB and Spo0A were required for the induction as well 
as maximum ywfH expression occurs at the onset of stationary phase.   
3.4.6 Deletion of codY Gene and Its Effect on the Expression of ywfH in Bacillus 
subtilis 
CodY, a GTP-binding protein that was first identified as a repressor of the Bacillus 
subtilis dipeptide permease (dppABCDE) operon. CodY regulates more than 100 
genes. The products of these genes are generally involved in the adaptation of 
bacterium to poor growth conditions. The repressor function of CodY is activated by 
interaction with two different effectors, GTP and isoleucine (Roggiani and  Dubnau, 
1993). Under slow-growth conditions like carbon limitation or as stationary phase 
approaches, the GTP level decreases because of ppGpp production or a reduction in 
GTP synthesis. In this case, the genes that are under CodY repression become 
actively transcribed because CodY loses its repressor activity (Serror and 
Sonenshein, 1996; Molle et al., 2003; Shivers and Sonenshein, 2004; Ratnayake-
Lecamwasam et al., 2001). 
The effect on competence can be attributed to the binding of CodY to the regulatory 
regions of two key early competence genes, srfAA and comK. CodY binding site in 
the srfA promoter region overlaps with the presumed RNA polymerase binding site 
but not with the ComA binding sites. Furthermore, srfA expression is proposed to be 
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repressed by CodY in the presence of casamino acids whether or not ComA is active. 
(Roggiani and  Dubnau, 1993). 
In order to monitor the effect of codY-null mutation on the expression of ywfH gene, 
codY was deleted in NAO1 (ywfH::lacZ::erm) by transforming the competent cells of 
trpC2 unkU::spc ∆codY mutant strain of PY79 (constructed by transforming the 
competent cells of Bacillus subtilis PY79 with chromosomal DNA of TMH307) with 
chromosomal DNA of the NAO1 strain with the selection for Erm (1μg/ml) and Spc 
(100μg/ml). The transformants were then screened on X-gal (40 μg/ml) IPTG, Erm 
(1μg/ml) and Spc (100μg/ml) containing agar plates for the confirmation of lacZ 
activity. One of the blue transformants was selected and designated as NAO6 
(ywfH::lacZ::erm  trpC2 unkU::spc ∆codY). 
Then codY-abrB double mutant strain was constructed by using NAO6 as competent 
cell. NAO6 was transformed with chromosomal DNA of ∆abrB::cat mutant strain 
derivative of B. subtilis. The transformants were screened for double antibiotic 
resistance to  Spc (100 μg/ml) and Cat (5 μg/ml). The selected mutant was named as 
NAO8 (∆abrB::cat  ywfH::lacZ::erm trpC2 unkU::spc ∆codY).  
In order to also examine the nutritional regulation system, in the absence of codY 
gene, casaminoacid (casein) addition was applied. So casein was added into growth 
medium of NAO6 with 0.1% final concentration. The resulting strain NAO6, NAO8, 
NAO6 with casein and NAO1 as control were cultured in PA medium and the 
specific activities of the samples were measured.  Growth profile of mutants was 
followed (Fig. 3.23, 3.24, 3.25, 3.26). 
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Figure 3.23:  Growth profile of  NAO6 (ywfH::lacZ::erm  trpC2 unkU::spc ∆codY),  
NAO8 (∆abrB::cat ywfH::lacZ::erm trpC2 unkU::spc ∆codY) , NAO6 
(ywfH::lacZ::erm  trpC2 unkU::spc ∆codY) with casein and NAO1 
(ywfH::lacZ::erm) strains grown in PA medium. The symbols used for the strains are; 
(▲) NAO1 (ywfH::lacZ::erm); (●) NAO8 (∆abrB::cat ywfH::lacZ::erm trpC2 
unkU::spc ∆codY); (■)NAO6 (ywfH::lacZ::erm  trpC2 unkU::spc ∆codY) with 
casein; (♦)NAO6 (ywfH::lacZ::erm  trpC2 unkU::spc ∆codY). 
 
Figure 3.24:  β-Galactosidase activities of NAO6 (ywfH::lacZ::erm  trpC2 
unkU::spc ∆codY) and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. 
Specific Miller Units was calculated with formula as denoted in Section 2.3. The 
symbols used for the strains are; (▲)NAO1 (ywfH::lacZ::erm) and (♦)NAO6 
(ywfH::lacZ::erm  trpC2 unkU::spc ∆codY). 
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Figure 3.25:  β-Galactosidase activities of NAO6 (ywfH::lacZ::erm  trpC2 
unkU::spc ∆codY), NAO8 (∆abrB::cat ywfH::lacZ::erm trpC2 unkU::spc ∆codY) 
and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. Specific Miller Units 
was calculated with formula as denoted in Section 2.3. The symbols used for the 
strains are; (▲) NAO1 (ywfH::lacZ::erm), (●) NAO8 (∆abrB::cat ywfH::lacZ::erm 
trpC2 unkU::spc ∆codY) (♦)NAO6 (ywfH::lacZ::erm  trpC2 unkU::spc ∆codY). 
 
 
Figure 3.26:  β-Galactosidase activities of NAO6 (ywfH::lacZ::erm  trpC2 
unkU::spc ∆codY) with casein, NAO6 (ywfH::lacZ::erm  trpC2 unkU::spc ∆codY) 
and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. Specific Miller Units 
was calculated with formula as denoted in Section 2.3. The symbols used for the 
strains are; (▲) NAO1 (ywfH::lacZ::erm), (■) NAO6 (ywfH::lacZ::erm  trpC2 
unkU::spc ∆codY) with casein (♦) NAO6 (ywfH::lacZ::erm  trpC2 unkU::spc 
∆codY). 
As seen in Figure 3.24 in codY-disrupted strain, ywfH expression severely decreased 
during stationary phase but did not become completely eliminated. But, this finding 
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was inconsistent with results of Inaoka et al. (2003) who reported that disruption of 
codY showed a positive effect on ywfH transcription. As shown in figure, the 
expression of ywfH gene in ∆abrB ∆codY double mutant (NAO8) was more than in 
∆codY mutant (NAO6).  Because β-Galactosidase activity of NAO8 might have 
pointted that a further abrB gene null mutation resulted in a relief on repression 
profile for ywfH gene expression in case of codY deleted mutant. Therefore, absence 
of AbrB, which is a repressor for the expression of genes in antibiotic production 
during exponential phase, has induced ywfH gene expression especially until the 
onset of stationary phase (Figure 3.25). Considering the fact that CodY is a very 
strong element of nutritional regulation circuit, as shown in Figure 3.26, addition of 
casein into medium of NAO6 showed that casein has a suppressive effect on β-
Galactosidase activity of NAO6 during stationary phase as expected. Consequently, 
it could have been said that ywfH gene is probably under control of CodY, effect of 
which is complemented by AbrB protein. 
3.4.7. Deletion of degU Gene and Its Effect on the Expression of ywfH Gene in 
Bacillus subtilis 
The DegS/DegU two-component system provides B. subtilis with a developmental 
switch between different adaptive processes. The two-component regulatory system 
DegS/DegU plays an important role in the regulation of secreting a large number of 
degradative enzymes during the transition from exponential to stationary growth in 
Bacillus subtilis. Phosphorylation of DegU is required for the production of 
degradative enzymes, but not for competence development (Hamoen et al., 2003; 
Msadek et al., 1995). On the other hand, degU mutation decreases the expression of 
srfA, an essential competence regulatory gene (Dubnau, 1991; Dahl et al., 1992). 
In order to examine the effect of degU null mutation, degU gene was deleted in the 
transcriptional ywfH::lacZ fusion strain NAO1. For this purpose, NAO1 was used as 
competent cell, then was transformed with the chromosomal DNA of ∆degU::kan 
mutant derivative of B. subtilis. The transformants were selected with regard to 
specific antibiotic resistance for Kan (10 μg/ml). Then selected mutant was named as 
NAO16 (∆deg U::kan  ywfH::lacZ::erm). 
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Figure 3.27:  Growth profile of  NAO16 (∆deg U::kan  ywfH::lacZ::erm) and 
NAO1 (ywfH::lacZ::erm) strains grown in PA medium. The symbols used for the 
strains are; (■) NAO16 (∆deg U::kanywfH::lacZ::erm); (♦)NAO1 
(ywfH::lacZ::erm).  
 
Figure 3.28:  β-Galactosidase activities of NAO16 (∆deg U::kan  ywfH::lacZ::erm) 
and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. The symbols used for the 
strains are; (■) NAO16 (∆deg U::kanywfH::lacZ::erm); (♦)NAO1 
(ywfH::lacZ::erm). 
As seen in Fig 3.28, ywfH expression was almost completely blocked when degU 
was deleted. DegU is an effective positive regulator of srf operon, so, it was 
proposed that the expression of ywfH gene has required not only degU gene but also 
srfA gene.  
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3.4.8. Deletion of sigmaB Gene and Its Effect on the Expression of ywfH Gene in 
Bacillus subtilis 
Transcription factor, σB was the first alternate sigma factor to be discovered in 
bacteria which is active during the stationary growth phase but its function is 
obscure. Transcription of the sigB gene begins in the early stationary phase when 
metabolic stress conditions or environmental signals are encountered (Benson and 
Haldenwang, 1992; Boylan et al., 1992). 
In order to monitor the effect of sigB null mutation, sigB gene was deleted in the 
transcriptional ywfH::lacZ fusion strain NAO1. For this purpose, NAO1 was used as 
competent cell, then was transformed with thw chromosomal DNA of ∆ML6::cat 
(sigB::cat) mutant derivative of B. subtilis. The transformants were selected with 
regard to specific antibiotic resistance for Cat (5μg/ml). Later on, the selected mutant 
was named as NAO17 (∆ML6::cat  ywfH::lacZ::erm) 
 
Figure 3.29:  Growth profile of  NAO17 (∆ML6::cat  ywfH::lacZ::erm) and NAO1 
(ywfH::lacZ::erm) strains grown in PA medium. The symbols used for the strains are; 
(■) NAO17 (∆ML6::cat  ywfH::lacZ::erm); (♦)NAO1 (ywfH::lacZ::erm). 
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Figure 3.30:  β-Galactosidase activities of NAO17 (∆ML6::cat  ywfH::lacZ::erm) 
and NAO1 (ywfH::lacZ::erm) strains grown in PA medium. The symbols used for the 
strains are; (■)NAO17 (∆ML6::cat  ywfH::lacZ::erm); (♦)NAO1 (ywfH::lacZ::erm). 
As observed in Fig. 3.30, sigB deletion mutation effected ywfH gene expression 
positively. Nevertheless, the increase was not very considerable. On the other hand, 
σB was required in response to stress conditions. With these facts, function of 
SigmaB was not considerable for ywfH expression. 
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4.  CONCLUSION 
In this study, ywfH::lacZ fusion mutant, NAO1 was constructed and the expression 
of ywfH::lacZ was observed by the help of β-galactosidase assay in PA medium.  
The results showed that the expression of ywfH increased slowly during the 
exponential phase and reached to maximal level upon entry into stationary phase in 
PA medium. 
In order to monitor the effects of global regulatory genes on the expression of ywfH 
gene, these genes were deleted on the ywfH::lacZ fusion mutant, NAO1 by the 
transformation and ywfH-directed β-galactosidase activities were subsequently 
analyzed.  
The disruption of srfA gene completely abolished ywfH::lacZ expression, suggesting 
that  the expression of ywfH gene depends on an intact surfactin operon. ywfH::lacZ 
expression in the oppA blocked mutant was severely abolished, indicating that 
product of oppA gene regulates ywfH gene expression as a part of quorum sensing 
mechnanism.  
The deletion of phrC, phrF and phrK genes impaired ywfH-lacZ expression in NAO 
12, NAO13 and NAO 14 respectively.  PhrC, PhrF and PhrK pheromone peptides are 
required for the expression of ywfH gene by enhancing the full activation of 
transcriptional factor ComA~P.  
In the result of comA, comP, comQ and spo0H genes deletion, ywfH::lacZ expression 
was entirely impaired, indicating that products of those genes has regulating effects 
on the expression of ywfH gene. ComP and ComX(ComQ) are required for 
phosphorylation and activation of ComA. On the other hand, the product of spo0H,  
σH is required for increased level of phr gene during transition state for inducing the 
activation of ComA. With these facts,  It is sensible to propose that the transcription 
of ywfH gene is ComA~P-dependent.  
The deletion of spo0A gene resulted in the fully elimination of ywfH::lacZ 
expression and this defect was relieved by a null mutation in abrB during exponential 
56 
 
growth which also was partially relieved during the stationary phase in spo0A-abrB 
double mutant. Otherwise, in abrB single mutant, the expression of ywfH gene 
increased with the absence of AbrB during exponential phase but not during 
stationary phase compared to NAO1. This present study generally showed that AbrB 
and Spo0A were required for the induction as well as the maximum ywfH expression 
occurs at the onset of stationary phase. ywfH::lacZ expression decreased in codY-
deleted mutant during exponential phase, and moreover this deletion strongly caused 
a decrease in ywfH::lacZ expression during the stationary phase. With the deletion of 
both codY and abrB genes, the expression of ywfH gene was relieved during 
exponential and stationary phase compared to codY-deleted single mutant. In order to 
identify the nutritional regulation in the absence of codY gene, casein was added as 
supplementery nutrient source in PA medium. The addition of casein into medium 
showed that casein had a suppressive effect on β-Galactosidase activity in 
ywfH::lacZ strain during stationary phase. Under the light of these results, it was 
proposed that CodY repressor which plays a key role in the initation of sporulation 
and genetic competence also plays a negative role in the expression of ywfH gene 
and this effect might be assisted by AbrB repressor protein.  
As a result of degU gene deletion in NAO1 strain, the expression of ywfH was almost 
fully blocked. Therefore, we suggested that DegU positively regulates the expression 
of ywfH gene. Finally, sigB deletion mutation did not make a considerable difference 
in ywfH expression. 
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APPENDIX A 
 
Luria Bertani (LB) Agar Medium (1000 ml) 
Tryptone 10 g/L 
Yeast Extract 5g/L 
NaCl2  5g/L 
Agar 15 g/L 
Distilled H2O was added up to 1000ml and then autoclaved for 4 minutes. 
2xYT Medium (1000ml) 
Tryptone 16 g 
Yeast Extract 10 g 
NaCl 5 g 
Agar  15 g 
(Added before autoclaving for solid 2xYT medium) 
HS medium (30 ml) 
10X-S-base 3 ml 
Glucose (50%) 300 μl 
Yeast Extract (10%) 300 μl 
Casaminoacid (2%)  300 μl 
Arg (8%) + His (0.4%) 3 ml 
Tryptophan (0.5%) 300 μl 
Phenylalanine (0.3%) 450 μl 
Completed up to 30 ml with sterile distilled H2O and store at cold (+4°C) for a week. 
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LS Medium (20 ml) 
10X-S-Base 2 ml 
Glucose 200 μl 
Tryptophan 200 μl 
Phenylalanine 30 μl 
Casaminoacid 100 μl 
Yeast Extract 200 μl 
Spermine (50mM) 200 μl 
MgCl2 (1M) (filter steriled) 50 μl 
Freshly prepared and completed up to 20 ml with sterile distilled H2O. 
Perry and Abraham (PA) Medium (pH 7.4) 
KH2PO4 1 g/L 
KCl 0.2 g/L 
MgSO4.7H2O* 0.5 g/L 
Glutamate.Na.H2O 4 g/L 
Sucrose* 10 g/L  
Ferric citrate** 0.15 g/L 
Trace elements**  1 ml 
CoCl2.6H2O 0.0001  g/L 
Ammonium molybdate 0.0001 g/L 
MnCl2.4H2O 0.001  g/L 
ZnSO4.7H2O 0.0001 g/L 
CuSO4.5H2O 0.00001 g/L 
*Autoclave separately 
**Filter sterilization 
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DSM Medium (Difco’s Sporulation Medium) 
Nutrient Broth     8 g 
KCl (10 %  w/v) 10 ml 
MgSO4.7H2O (1.2 %) 10 ml 
NaOH (1 M) 0.5 ml 
Autoclaved for 30 min. and cooled own to 50 
◦
C. 
Ca(NO3)4 (1 M) 1 ml 
MnCl2 (0.01 M) 1 ml 
FeSO4 (1 mM) 1 ml  (resuspended before use) 
1.5 % Agar was added if needed. 
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APPENDIX B 
 
P1 Buffer (pH 8) 
 
Tris-base 6.06 gr 
EDTA.2H2O  3.72 gr 
Dissolve Tris-base and EDTA with 800 ml dH2O. Adjust pH to 8 with HCl. Adjust 
volume to 1 L dH2O. Add 100 mg RNaseA per liter of P1. 
P2 Buffer 
NaOH 8 gr 
SDS solution (20%)  50 ml 
Dissolve NaOH in 950 ml dH2O. Add 50 ml SDS solution. 
P3 Buffer  (pH 5.5) 
Potassium acetate 294.5 gr 
Dissolve in 500 ml dH2O. Adjust pH 
TE Buffer (pH 7) 
Tris base 10 mM 
EDTA 1 mM 
Adjusted pH 7 with HCl 
TAE Buffer (50X) 
Tris base (2 moles)  242 g 
Glacial acetic acid 57.1 ml 
EDTA 100 ml (0.5 M, pH 8.0) 
Add Distilled H2O up to 1 L and adjust pH to 8 by HCl. 
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Low Melting Agarose Gel (1%) 
Agarose 0.5 g 
TAE buffer (1X) 50 ml 
Add 1.5μl EtBr (final concentration: 0.5 μg/ml) before pouring the gel into tray. 
CTAB/NaCl Solution (10 % CTAB/ 0.7 M NaCl) 
4.1 g of NaCl was dissolved in 80 mL of dH2O. Then, 10 g of CTAB (hexadecyl 
trimethyl ammonium bromide) was added and dissolved with vigorously shaking 
and gentle heating up to 65 °C. Final volume was made up to 100 mL with dH2O. 
Physiological Sodium Chloride Solution (0.85%) (1000 ml) 
NaCl2 8.5 g 
Dissolve in 1000 ml distilled water and autoclave. 
Tris-Cl Solution (25mM, 1000 ml, pH 7.4) 
Tris (hydromethyl)aminomethane 3.03 g 
Dissolve in 1000ml distilled water and adjust pH to 7.4 with HCl (1 M) 
Z Buffer (500 ml, pH 7.0) 
Na2HPO4.7H2O  (60mM) 5.33 g 
NaH2PO4             (40 mM) 3.12 g 
KCl2                     (10 mM) 0.373 g 
MgSO4.7H2O       (1 mM) 0.123 g 
All mixed and dissolved within 500 ml distilled water and the pH was adjusted to a 
value of 7.0. 
β-mercaptoethanol final concentration:      270 μl / 100 ml (add to Z buffer on 
immediately before using) 
Lysozyme final concentration: 2.5 mg/ml 
ONPG final concentration: 4.0 mg/ml 
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APPPENDIX C 
 
Chemicals Suppliers 
Agar Bacteriological AppliChem 
Agarose Prona 
Ammonium persulfate Carlo Erba 
Arginine Merck 
CaCl2.2H2O Merck 
Casamino acid AppliChem 
Cloramphenicol  Sigma 
CoCl2.6H2O  Carlo Erba 
CuSO4.5H2O  Carlo Erba 
CTAB                 Sigma 
EDTA Sigma 
Ethanol Botafarma 
Ethidium bromide Sigma 
Glucose Riedel deHaen 
Glycerol Merck 
HCl Carlo Erba 
Histidine Merck 
IPTG Sigma 
KH2PO4 J.T.Baker 
K2HPO4 J.T.Baker 
KCl Carlo Erba 
Mercaptoethanol Merck 
MgCl2.6H2O Carlo Erba 
MgSO4.7H2O Carlo Erba 
MnCl2.4H2O Carlo Erba 
Na2CO3 Riedel deHaen 
Na3citrate.2H2O Riedel deHaen 
NaCl Carlo Erba 
NaOH Carla Erba 
2-Nitrophyl β-D-galacto pyranoside (ONPG) Sigma 
Nutrient Broth Merck 
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Chemicals Suppliers 
PEG 8000 Merck 
Phenol-chloroform-isoamylalcohol Fluka 
Phenylalanin Merck 
SDS Merck 
Spermine Fluka 
Sucrose Merck 
Tris-base Merck 
Triton-X100 Sigma 
Trypton Acumedia 
Tryptophan Merck 
X-Gal Sigma 
Yeast Extract Acumedia 
 
 
Enzymes 
BamHI Fermentas 
HindIII Fermentas 
Lysozyme AppliChem 
Proteinase K Sigma 
RNAse A Sigma 
Taq DNA Polymerase Fermentas 
T4 DNA Ligase Roche 
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APPENDIX D 
 
Marker                                                                                       Supplier 
Lambda DNA/EcoRI+ HindIII Marker  (Marker 3)                   MBI Fermentas 
 
 
 
ΦX174 DNA/HinfI Marker (Marker 10)                                    MBI Fermentas 
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APPENDIX E 
 
ywfH DNA Sequence 
 
TTGTCAAAACGAACCGCATTTGTTATGGGAGCCAGTCAAGGGATCGGGA
AAGCAATCGCTCTGAAATTAGCAGACCAGCACTTTTCCCTCGTCATTAAT
TCGCGAAATTTGGATAATATTGAATCTGTCAAAGAAGACATTTTGGCCAA
GCATCCTGAGGCGAGCGTCATTGTCCTTGCGGGCGATATGTCTGACCAGC
ATACGAGAGCGGGCATTTTTCAGAAAATCGAATCTCAATGCGGACGGCTT
GATGTTCTGATTAATAATATCCCGGGCGGCGCGCCTGACACATTTGATAA
CTGCAATATAGAGGATATGACGGCCACGTTCACTCAAAAGACCGTTGCCT
ATATTGACGCAATCAAGCGTGCTTCCTCACTGATGAAACAAAACGAGTTT
GGCAGAATCATCAACATTGTCGGAAATCTGTGGAAAGAACCCGGCGCCA
ACATGTTCACAAACAGTATGATGAATGCCGCTTTAATTAACGCCAGTAAA
AATATTTCCATCCAGCTTGCTCCTCACAACATTACTGTCAACTGTCTGAAT
CCTGGTTTTATCGCTACAGACCGTTATCATCAATTTGTGGAAAATGTGAT
GAAAAAGAACAGCATATCCAAACAGAAAGCAGAAGAACAGATTGCTTCC
GGGATTCCGATGAAACGGGTCGGATCAGCCGAAGAAACCGCAGCGCTCG
CCGCATTTCTTGCCTCTGAGGAAGCCTCCTACATCACGGGACAGCAAATT
TCCGCTGACGGCGGCAGCATGAAAAGCATATAA 
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